http://trialreach.com/premium/Clinical-Trial-on-New-Antidepressant-Medication-for-Patients-with-Depression/86574/2011-02-13weekly0.9http://trialreach.com/premium/Clinical-Trial-for-Patients-with-House-Dust-Mite-Allergy/112756/2011-10-05weekly0.9http://trialreach.com/premium/Clinical-Trial-for-Myelodysplastic-Patients-With-Transfusional-Iron-Overload/61278/2010-07-21weekly0.9http://trialreach.com/premium/A-Clinical-Trial-For-Patients-With-Non-Small-Cell-Lung-Cancer/108388/2011-07-19weekly0.9http://trialreach.com/study/A-Phase-I-Study-of-Quadrivalent-Human-Papilloma-Virus-HPV-Types-6-11-16-18-Recombinant-Vaccine-in-HIV-Infected-and-HIV-N/42963/2012-02-01weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Eslicarbazepine-Acetate-Monotherapy-in-Subjects-With-Partial-Epilepsy-Not-Well-Controlled-by-Curr/110476/2012-02-01weekly0.1http://trialreach.com/study/Study-To-Evaluate-The-Efficacy-And-Safety-Of-PH-797804-For-12-Weeks-In-Adults-With-Moderate-To-Severe-Chronic-Obstructiv/97441/2012-02-01weekly0.1http://trialreach.com/study/CYCORE-Feasibility/93593/2012-02-01weekly0.1http://trialreach.com/study/Emergency-Department-Based-Palliative-Care-for-Advanced-Cancer-Patients/103002/2012-02-01weekly0.1http://trialreach.com/study/Safety-Tolerability-and-Pharmacokinetics-of-Single-Dose-Intravenous-Moxifloxacin-in-Pediatric-Patients/44179/2012-02-01weekly0.1http://trialreach.com/study/Evaluation-and-Treatment-of-Patients-With-Epilepsy/5286/2012-02-01weekly0.1http://trialreach.com/study/Eslicarbazepine-Acetate-Monotherapy-Long-Term-Study/28757/2012-02-01weekly0.1http://trialreach.com/study/Training-Effects-on-Skeletal-Muscle-Fatty-Acid-Metabolism/72582/2012-02-01weekly0.1http://trialreach.com/study/Evaluate-SafetyTolerability-Intra-Arterial-Temozolomide-in-Patients-wExtremity-Melanoma-by-Isolated-Limb-Infusion/104759/2012-02-01weekly0.1http://trialreach.com/study/Hand-Function-for-Tetraplegia/27770/2012-02-01weekly0.1http://trialreach.com/study/Gene-Therapy-for-Chronic-Granulomatous-Disease/75073/2012-02-01weekly0.1http://trialreach.com/study/LeucoPatch-Study-A-Multicenter-Study-on-the-Effect-of-LeucoPatch-in-Diabetic-Foot-Ulcers/119384/2012-02-01weekly0.1http://trialreach.com/study/Combination-Targeted-Radiotherapy-in-Neuroendocrine-Tumors/96930/2012-02-01weekly0.1http://trialreach.com/study/Immunotherapy-Study-for-Surgically-Resected-Pancreatic-Cancer/98526/2012-02-01weekly0.1http://trialreach.com/study/Safety-and-Tolerability-Study-of-Oral-OPC-34712-as-Maintenance-Treatment-in-Adults-With-Schizophrenia/87269/2012-02-01weekly0.1http://trialreach.com/study/Study-of-UshStat-in-Patients-With-Retinitis-Pigmentosa-Associated-With-Usher-Syndrome-Type-1B/119403/2012-02-01weekly0.1http://trialreach.com/study/Study-of-Biomarkers-in-Blood-and-Bone-Marrow-Samples-From-Patients-With-Previously-Untreated-Chronic-Lymphocytic-Leukemi/7931/2012-02-01weekly0.1http://trialreach.com/study/Nurse-Case-Manager-Model-on-Neuroblastoma-Caregivers-Uncertainty/119341/2012-02-01weekly0.1http://trialreach.com/study/Exploratory-CSII-Trial-on-Erectile-Dysfunction-in-T2DM-Patients/113104/2012-02-01weekly0.1http://trialreach.com/study/Comparing-LipiodolEthanol-With-Drug-eluting-Beads-DEB-for-Hepatocellular-Carcinoma/119382/2012-02-01weekly0.1http://trialreach.com/study/Ultrasound-Guided-Arterial-Line-Placement-in-Long-Axis-Versus-Short-Axis-in-Pediatric-Patients/16997/2012-02-01weekly0.1http://trialreach.com/study/Combination-of-Nebivolol-and-Valsartan-Given-as-Free-Tablets-for-Stage-1-or-Stage-2-Hypertension/100591/2012-02-01weekly0.1http://trialreach.com/study/A-Study-of-ARRY-614-in-Patients-With-Low-or-Intermediate-1-Risk-Myelodysplastic-Syndromes/113459/2012-02-01weekly0.1http://trialreach.com/study/Study-of-Nerve-Reconstruction-Using-AVANCE-in-Subjects-Who-Undergo-Robotic-Assisted-Prostatectomy-for-Treatment-of-Prost/78156/2012-02-01weekly0.1http://trialreach.com/study/Ranolazine-for-the-Prevention-of-Atrial-Fibrillation-After-Electrical-Cardioversion/95983/2012-02-01weekly0.1http://trialreach.com/study/Stereotactic-Body-Radiation-Therapy-in-Liver-Cancer-That-Cannot-be-Removed-by-Surgery-or-Transplant/90388/2012-02-01weekly0.1http://trialreach.com/study/Study-of-BMN-673-a-PARP-Inhibitor-in-Patients-With-Advanced-Hematological-Malignancies/99508/2012-02-01weekly0.1http://trialreach.com/study/A-Safety-Study-of-IMOVAX-Polio-Vaccine-in-Selected-Cities-in-China/95257/2012-02-01weekly0.1http://trialreach.com/study/Treating-Clozapine-induced-Sinustachycardia-With-Bisoprolol/6131/2012-02-01weekly0.1http://trialreach.com/study/Mental-Stress-Reduction-in-Defibrillator-Patients/83488/2012-02-01weekly0.1http://trialreach.com/study/AV-Nodal-Reentrant-Tachycardia-Study/13269/2012-02-01weekly0.1http://trialreach.com/study/Assessment-of-Normal-Value-of-Acoustic-Radiation-Force-Impulse-ARFI-Elastography-in-HIV-Patients/92219/2012-02-01weekly0.1http://trialreach.com/study/Family-EatsCancer-Prevention-for-Families/81598/2012-02-01weekly0.1http://trialreach.com/study/Travacom-Post-Marketing-Surveillance-Study/119337/2012-02-01weekly0.1http://trialreach.com/study/Vitamin-D-and-Grass-Pollen-Specific-Immunotherapy/119345/2012-02-01weekly0.1http://trialreach.com/study/A-Phase-1-Study-of-PPI-668-in-Healthy-Volunteers-and-Patients-With-Hepatitis-C-Virus-HCV-Genotype-1/119373/2012-02-01weekly0.1http://trialreach.com/study/Ablation-of-Inappropriate-Sinus-Tachycardia/44962/2012-02-01weekly0.1http://trialreach.com/study/The-Efficacy-of-Human-Acellular-Dermal-Matrix-in-the-Treatment-of-Anal-Fistula/84790/2012-02-01weekly0.1http://trialreach.com/study/A-Study-of-ARRY-520-in-Patients-With-Relapsed-or-Refractory-Multiple-Myeloma/17269/2012-02-01weekly0.1http://trialreach.com/study/Varenicline-Smoking-Cessation-Treatment-for-Methadone-Maintenance-Patients/104916/2012-02-01weekly0.1http://trialreach.com/study/A-Trial-of-Memantine-Versus-Placebo-in-Children-With-Autism/87117/2012-02-01weekly0.1http://trialreach.com/study/Lymphadenectomy-In-Ovarian-Neoplasms/39659/2012-02-01weekly0.1http://trialreach.com/study/Identifying-Prognostic-Factors-in-Frontline-FCR-for-Patients-With-Chronic-Lymphocytic-Leukemia-CLL/56011/2012-02-01weekly0.1http://trialreach.com/study/Pazopanib-in-Advanced-Gastrointestinal-Stromal-Tumors-Refractory-to-Imatinib-and-Sunitinib/119393/2012-02-01weekly0.1http://trialreach.com/study/Preoperative-Chemotherapy-in-Triple-Negative-Invasive-Breast-Cancer-That-Can-be-Removed-by-Surgery/46221/2012-02-01weekly0.1http://trialreach.com/study/Safety-Study-of-Combined-Systemic-and-Intraperitoneal-Chemotherapy-to-Treat-Stomach-Cancer/119334/2012-02-01weekly0.1http://trialreach.com/study/FOLFIRINOX-in-Patients-With-Inoperable-Pancreatic-Cancer/103480/2012-02-01weekly0.1http://trialreach.com/study/Implementing-a-Comprehensive-Handoff-Program-to-Improve-Patient-Safety/92455/2012-02-01weekly0.1http://trialreach.com/study/Ginkgo-Biloba-Extract-for-Schizophrenia/119349/2012-02-01weekly0.1http://trialreach.com/study/ACute-and-Chronic-Effects-of-Saxagliptin/119329/2012-02-01weekly0.1http://trialreach.com/study/Boston-Early-Onset-Chronic-Obstructive-Pulmonary-Disease-COPD-Study/91341/2012-02-01weekly0.1http://trialreach.com/study/Outcomes-of-a-DIEP-Flap-Program/58233/2012-02-01weekly0.1http://trialreach.com/study/Capecitabine-Temozolomide-and-Bevacizumab-for-Metastatic-or-Unresectable-Pancreatic-Neuroendocrine-Tumors/119348/2012-02-01weekly0.1http://trialreach.com/study/Mind-Body-Program-for-Cancer-Patients/17537/2012-02-01weekly0.1http://trialreach.com/study/Structural-and-Functional-Neuroimaging-Studies-of-Combat-Veterans/107568/2012-02-01weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Studies-of-Panobinostat-and-Bicalutamide-in-Patients-With-Recurrent-Prostate-Cancer-After-Castration/119401/2012-02-01weekly0.1http://trialreach.com/study/Entinostat-and-Lapatinib-Ditosylate-in-Patients-With-Locally-Recurrent-or-Distant-Relapsed-Metastatic-Breast-Cancer-Prev/119359/2012-02-01weekly0.1http://trialreach.com/study/Affect-of-RT-CGMS-as-Part-of-Clinical-Care-in-Type-1-Diabetes-Mellitus-Patients/119336/2012-02-01weekly0.1http://trialreach.com/study/IL15-Dendritic-Cell-Vaccine-for-Patients-With-Resected-Stage-IIIc-and-Stage-IV-Melanoma/100575/2012-02-01weekly0.1http://trialreach.com/study/Cholecalciferol25-OH-Vitamin-D-in-Treating-Patients-With-Colorectal-Cancer/109077/2012-02-01weekly0.1http://trialreach.com/study/Synchronized-Transcranial-Magnetic-Stimulation-sTMS-in-Major-Depressive-Disorder/110987/2012-02-01weekly0.1http://trialreach.com/study/Study-of-Treatment-of-Depression-in-Refractory-Asthma/99433/2012-02-01weekly0.1http://trialreach.com/study/A-Comparative-Post-marketing-Study-of-Commercially-Available-Peripheral-Nerve-Gap-Repair-Options/41042/2012-02-01weekly0.1http://trialreach.com/study/Quality-of-Life-of-Older-Patients-Who-Are-Undergoing-Treatment-for-Cancer-and-of-Their-Family-Caregivers/59611/2012-02-01weekly0.1http://trialreach.com/study/FLuctuATion-Reduction-With-inSULin-and-Glp-1-Added-togetheR-FLAT-SUGAR/119354/2012-02-01weekly0.1http://trialreach.com/study/Bispectral-Index-Monitoring-During-Testing-in-the-Electrophysiology-Lab/2046/2012-02-01weekly0.1http://trialreach.com/study/Investigation-of-the-Safety-Tolerability-and-Potential-Therapeutic-Effects-of-JNJ-40411813-in-Patients-With-Schizophreni/102745/2012-02-01weekly0.1http://trialreach.com/study/Brain-Nicotine-Receptor-Density--Response-to-Nicotine-Patch/119371/2012-02-01weekly0.1http://trialreach.com/study/Home-Use-of-Cupping-Massage-in-Chronic-Neck-Pain/119347/2012-02-01weekly0.1http://trialreach.com/study/Thymus-Transplantation-Safety-Efficacy/98029/2012-02-01weekly0.1http://trialreach.com/study/Analysis-of-Surgery-in-Patients-Presenting-With-Stage-IV-Breast-Cancer/69244/2012-02-01weekly0.1http://trialreach.com/study/Sunitinib-Malate-in-Treating-Patients-With-Previously-Untreated-Metastatic-Kidney-Cancer/106059/2012-02-01weekly0.1http://trialreach.com/study/Feasibility-of-VMAT-and-CBCT-for-Head-and-Neck-Carcinomas/109412/2012-02-01weekly0.1http://trialreach.com/study/Internal-Fixation-of-Hip-Fractures-Using-Intraoperative-Simultaneous-Two-Axis-View/119328/2012-02-01weekly0.1http://trialreach.com/study/Study-of-NNZ-2566-in-Patients-With-Traumatic-Brain-Injury-Under-EFIC/111554/2012-02-01weekly0.1http://trialreach.com/study/Phase-4-Study-of-Greenlight-XPS-Laser-Versus-BiVAP-Saline-Vaporization-of-the-Prostate-in-Men-With-Symptomatic-Benign-Pr/119379/2012-02-01weekly0.1http://trialreach.com/study/Patient-Controlled-Tissue-Expansion-for-Breast-Reconstruction/119351/2012-02-01weekly0.1http://trialreach.com/study/Influence-of-Perioperative-Hypnotherapy-on-Postoperative-Improvement-in-Cognitive-Performance/119338/2012-02-01weekly0.1http://trialreach.com/study/SS1dsFVPE38-Plus-Pemetrexed-and-Cisplatin-to-Treat-Malignant-Pleural-Mesothelioma/119355/2012-02-01weekly0.1http://trialreach.com/study/A-Pharmacodynamic-Study-With-Ticagrelor-in-African-American-Patients/119407/2012-02-01weekly0.1http://trialreach.com/study/Continuous-Glucose-Monitoring-by-Subcutaneous-Measurement-Compared-to-Frequent-Point-of-Care-Measurement-by-Accu-Chek-in/119360/2012-02-01weekly0.1http://trialreach.com/study/Phase-1-Study-of-PI3-Phosphatidylinositol-3-Kinase-Inhibitor-BAY80-6946-With-Gemcitabine-or-Cisplatin-Plus-Gemcitabine-i/119330/2012-02-01weekly0.1http://trialreach.com/study/M-D-Anderson-Symptom-Inventory---Ovarian-Cancer/15961/2012-02-01weekly0.1http://trialreach.com/study/Lenalidomide-Lenalidomide--Azacitidine-or-Standard-Treatment-Therapies-in-Newly-Diagnosed-Acute-Myeloid-Leukemia/92688/2012-02-01weekly0.1http://trialreach.com/study/Study-To-Assess-the-Dietary-Carbohydrate-Content-of-Indian-Diabetic-Population/119353/2012-02-01weekly0.1http://trialreach.com/study/Reliability-of-Central-Venous-Pressure-Measurements/108427/2012-02-01weekly0.1http://trialreach.com/study/Differences-in-Timely-Cancer-Diagnosis-in-African-American-and-Caucasian-Patients-With-Newly-Diagnosed-Colorectal-Cancer/28735/2012-02-01weekly0.1http://trialreach.com/study/Impact-of-Personalized-Feedback-Alone-on-Substance-Use-Behaviors/119400/2012-02-01weekly0.1http://trialreach.com/study/Standard-Reaming-Versus-ReamingIrrigatingAspirating-for-Intramedullary-Nailing-of-Femoral-Shaft-Fractures/28468/2012-02-01weekly0.1http://trialreach.com/study/Rotigotine-Versus-Placebo-to-Evaluate-the-Efficacy-on-Depressive-Symptoms-in-Idiopathic-Parkinsons-Disease-Patients/119344/2012-02-01weekly0.1http://trialreach.com/study/Primovist--Eovist-in-Renally-Impaired-Patients/72340/2012-02-01weekly0.1http://trialreach.com/study/Comparison-of-the-Protective-Effect-of-Desflurane-and-Propofol-in-Patients-With-Renal-Transplantation/107511/2012-02-01weekly0.1http://trialreach.com/study/Ofatumumab-and-Bortezomib-for-Patients-With-Low-grade-B-cell-Non-hodgkin-Lymphoma-That-Relapse-After-Rituximab/110505/2012-02-01weekly0.1http://trialreach.com/study/A-Health-Economic-Trial-in-Adult-Patients-Undergoing-Open-Colectomy-MA402S23B302/119339/2012-02-01weekly0.1http://trialreach.com/study/Changes-in-Breast-Density-and-Breast-Cancer-Risk-in-Women-With-Breast-Cancer-and-in-Healthy-Women/45572/2012-02-01weekly0.1http://trialreach.com/study/A-Study-of-the-Effectiveness-and-Safety-of-Different-Doses-of-Fluticasone-Propionate-Taken-From-a-Dry-Powder-Inhaler-in-/119406/2012-02-01weekly0.1http://trialreach.com/study/National-Study-on-Listeriosis-and-Listeria/119350/2012-02-01weekly0.1http://trialreach.com/study/Safety-Study-to-Evaluate-Monoclonal-Antibody-KW-0761-in-Subjects-With-Peripheral-T-cell-Lymphoma/30892/2012-02-01weekly0.1http://trialreach.com/study/Establishment-of-a-Bank-of-Biospecimens-for-Future-Research-on-Age-related-Cognitive-Disorders/20765/2012-02-01weekly0.1http://trialreach.com/study/An-Interactive-Web-Based-Program-to-Improve-Food-and-Activity-Choices-of-Teens/26460/2012-02-01weekly0.1http://trialreach.com/study/Volumetric-Modulated-Arc-Therapy-VMAT-for-Brain-Metastases/59574/2012-02-01weekly0.1http://trialreach.com/study/Amyloid-Imaging-And-Safety-Study-Of-Subcutaneous-Bapineuzumab-In-Subjects-With-Mild-to-Moderate-Alzheimers-Disease/97343/2012-02-01weekly0.1http://trialreach.com/study/Arthroscopic-Debridement-for-Chondral-Lesions-in-the-Knee/119352/2012-02-01weekly0.1http://trialreach.com/study/Polycystic-Ovary-Syndrome---Improving-Outcomes/119404/2012-02-01weekly0.1http://trialreach.com/study/A-Randomized-Clinical-Trial-of-the-Effect-of-Pimecrolimus-Cream-1-Compared-With-Topical-Corticosteroid-in-Treatment-of-E/119364/2012-02-01weekly0.1http://trialreach.com/study/Complete-Neoadjuvant-Treatment-for-REctal-Cancer-CONTRE/110769/2012-02-01weekly0.1http://trialreach.com/study/Irinotecan-Plus-Brivanib-in-Metastatic-Colorectal-Cancer-CRC-Enriched-for-Elevated-Levels-of-Plasma-FGF/88763/2012-02-01weekly0.1http://trialreach.com/study/Orthotics-in-Ambulatory-Cerebral-Palsy/119383/2012-02-01weekly0.1http://trialreach.com/study/Study-of-Oxaliplatin-and-Xeloda-and-Cetuximab-as-First-Line-Treatment-for-Metastatic-or-Unresectable-Gastric-or-Gastroes/52721/2012-02-01weekly0.1http://trialreach.com/study/Prospective-Randomized-Evaluation-Of-Celecoxib-Integrated-Safety-Vs-Ibuprofen-Or-Naproxen/73254/2012-02-01weekly0.1http://trialreach.com/study/The-Impact-of-Nebivolol-Versus-Metoprolol-on-Quality-of-Life/119362/2012-02-01weekly0.1http://trialreach.com/study/Study-of-the-Effectiveness-of-Three-Different-Doses-of-OPC-34712-in-the-Treatment-of-Adults-With-Acute-Schizophrenia/104507/2012-02-01weekly0.1http://trialreach.com/study/Detecting-Infections-Rapidly-and-Easily-for-Candidemia-Trial-DIRECT/119361/2012-02-01weekly0.1http://trialreach.com/study/Vascular-and-Cognitive-Assessments-in-Patients-With-Breast-Cancer-Undergoing-Chemotherapy-After-Surgery/119342/2012-02-01weekly0.1http://trialreach.com/study/Phase-I-II-Everolimus-and-Sorafenib-in-Recurrent-High-Grade-Gliomas/119356/2012-02-01weekly0.1http://trialreach.com/study/High-Dose-Chemotherapy-and-Autologous-Transplant-for-Neuroblastoma/119388/2012-02-01weekly0.1http://trialreach.com/study/Use-of-Continuous-Passive-Motion-in-the-Post-Operative-Treatment-of-Intra-articular-Knee-Fractures/33656/2012-02-01weekly0.1http://trialreach.com/study/Effect-of-Sarcosine-on-Symptomatology-Quality-of-Life-Oxidative-Stress-and-Glutamatergic-Parameters-in-Schizophrenia/119335/2012-02-01weekly0.1http://trialreach.com/study/Differences-Between-the-Bayley-II-and-the-Bayley-III-in-Very-Preterm-Infants-at-2-Years/105874/2012-02-01weekly0.1http://trialreach.com/study/Clinical-Trial-in-22q13-Deletion-SyndromePhelan-McDermid-Syndrome/119399/2012-02-01weekly0.1http://trialreach.com/study/Multiple-Dose-Pharmacokinetics-PK-and-Pharmacodynamic-PD-Effect-of-NSI-189-Phosphate-in-Depression-Patient-Subjects/119363/2012-02-01weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-MRI-based-Thrombolysis-in-Wake-up-Stroke/119331/2012-02-01weekly0.1http://trialreach.com/study/A-Health-Economic-Trial-in-Adult-Patients-Undergoing-Ileostomy-Reversal-MA402S23B504/119358/2012-02-01weekly0.1http://trialreach.com/study/Impact-on-Mid-term-Mortality-of-Guidelines-for-ICU-Admission-of-Elderly-Patients-Arriving-in-Emergency-Departments/119376/2012-02-01weekly0.1http://trialreach.com/study/Bridging-Study-for-Killed-Oral-Cholera-Vaccine-in-Ethiopia/119366/2012-02-01weekly0.1http://trialreach.com/study/Observational-Study-to-Evaluate-the-Correctness-of-the-Use-of-Inhaler-Device-in-Patients-With-Asthma-or-Chronic-Obstruct/119343/2012-02-01weekly0.1http://trialreach.com/study/The-Effect-of-Moxonidine-on-Blood-Pressure-and-Regression-of-Early-Target-Organ-Damage-in-Young-Subjects-With-Abdominal-/108978/2012-02-01weekly0.1http://trialreach.com/study/New-Markers-to-Measure-Clotting-in-Patients-With-the-Obstructive-Sleep-Apnoea-Hypopnoea-Syndrome/119402/2012-02-01weekly0.1http://trialreach.com/study/A-Health-Economic-Trial-in-Adult-Patients-Undergoing-Ileostomy-Reversal-MA402S23B501/119365/2012-02-01weekly0.1http://trialreach.com/study/Study-of-the-Large-Diameter-GORE-EXCLUDER-AAA-Endoprosthesis-in-Abdominal-Aneurysms/61939/2012-02-01weekly0.1http://trialreach.com/study/Methoxyamine-and-Temozolomide-in-Treating-Patients-With-Advanced-Solid-Tumors/65295/2012-02-01weekly0.1http://trialreach.com/study/A-Prospective-Study-Evaluating-The-Utility-of-Transnasal-Endoscopy-With-Roux-en-Y-Gastric-Bypass/119381/2012-02-01weekly0.1http://trialreach.com/study/Yoga-Based-Cancer-Rehabilitation-Program/54188/2012-02-01weekly0.1http://trialreach.com/study/Endurant-Stent-Graft-System-in-the-Treatment-of-Infra-renal-Abdominal-Aortic-Aneurysms-ENDURANT-France/119333/2012-02-01weekly0.1http://trialreach.com/study/Evaluation-of-the-Pharmacodynamic-Effect-of-the-Combination-of-Sildenafil-and-Riociguat-on-Blood-Pressure-and-Other-Safe/94448/2012-02-01weekly0.1http://trialreach.com/study/Hearing-Loss-and-Dizziness-in-Patients-Receiving-Oxaliplatin-for-Solid-Tumors/50439/2012-02-01weekly0.1http://trialreach.com/study/Strategies-to-Improve-Asthma/119346/2012-02-01weekly0.1http://trialreach.com/study/Validation-of-the-Rhinitis-Control-Scoring-System-RCSS/69827/2012-02-01weekly0.1http://trialreach.com/study/Simple-Versus-Radical-Hysterectomy-for-Stage-I-Cervical-Cancer/40956/2012-02-01weekly0.1http://trialreach.com/study/Study-of-the-BiovaxId-Tumor-Derived-Idiotype-Vaccine-in-Patients-With-Follicular-Lymphoma/19554/2012-02-01weekly0.1http://trialreach.com/study/Red-Blood-Cell-RBC-Survival-Following-Transfusion-in-Infants/27777/2012-02-01weekly0.1http://trialreach.com/study/Evaluation-of-Skeletal-Muscle-Lipid-Content-by-Magnetic-Resonance-Spectroscopy/22745/2012-02-01weekly0.1http://trialreach.com/study/Prospective-Study-on-the-Feasibility-and-Effectiveness-of-Per-Oral-Endoscopic-Myotomy-POEM-for-Treatment-of-Primary-Esop/119357/2012-02-01weekly0.1http://trialreach.com/study/Magnesium-Supplements-In-The-Treatment-Of-Pseudoxanthoma-Elasticum-PXE/119405/2012-02-01weekly0.1http://trialreach.com/study/Preoperative-Treatment-With-Cetuximab-andor-IMC-A12/76984/2012-02-01weekly0.1http://trialreach.com/study/IMA910-Plus-GM-CSF-With-Low-dose-Cyclophosphamide-Pre-treatment-in-Advanced-Colorectal-Carcinoma-Patients-Following-a-Su/67317/2012-02-01weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Alogliptin-Plus-Metformin-Compared-to-Glipizide-Plus-Metformin-in-Subjects-With-Type-2-Diabetes-M/59989/2012-02-01weekly0.1http://trialreach.com/study/Treatment-With-Dasatinib-in-Patients-With-Acral-Lentiginous-Mucosal-or-Chronic-Sun-damaged-Melanoma/104677/2012-02-01weekly0.1http://trialreach.com/study/ZevalinBEAMRituximab-vs-BEAMRituximab-With-or-Without-Rituximab-in-Autologous-Stem-Cell-Transplantation/84606/2012-02-01weekly0.1http://trialreach.com/study/A-Randomized-Double-blind-Placebo-controlled-Combined-Single-Ascending-Dose-and-Multiple-Ascending-Dose-Study/108290/2012-02-01weekly0.1http://trialreach.com/study/Rocking-Motion-Physiologic-Effect-on-the-Surgical-Stress-Response/108670/2012-02-01weekly0.1http://trialreach.com/study/Effects-of-Sitagliptin-on-Type-2-Diabetes-Mellitus-Patients-on-Treatment-With-Metformin-and-Insulin/102889/2012-02-01weekly0.1http://trialreach.com/study/Vaccine-Therapy-in-Treating-Patients-With-Stage-III-or-Stage-IV-Melanoma/43026/2012-02-01weekly0.1http://trialreach.com/study/The-Kiva-System-as-a-Vertebral-Augmentation-Treatment/111057/2012-02-01weekly0.1http://trialreach.com/study/Sorafenib-as-Adjuvant-Treatment-in-the-Prevention-Of-Recurrence-of-Hepatocellular-Carcinoma-STORM/78622/2012-02-01weekly0.1http://trialreach.com/study/Double-Push-Acoustic-Radiation-Force-DP-ARF-Ultrasound-for-Monitoring-Degeneration-in-Duchenne-Muscular-Dystrophy/119374/2012-02-01weekly0.1http://trialreach.com/study/Study-of-BMN-673-a-PARP-Inhibitor-in-Patients-With-Advanced-or-Recurrent-Solid-Tumors/97846/2012-02-01weekly0.1http://trialreach.com/study/Safety-Tolerability-and-Efficacy-of-YH14618-in-Patients-With-Degenerative-Disc-Disease/119332/2012-02-01weekly0.1http://trialreach.com/study/Prenatal-Iron-and-Malaria-Study/96517/2012-02-01weekly0.1http://trialreach.com/study/Study-of-Tumor-Tissue-Samples-From-Patients-With-Stage-I-Stage-II-or-Stage-III-Malignant-Melanoma/68899/2012-02-01weekly0.1http://trialreach.com/study/Study-to-Evaluate-Effect-of-a-Single-Dose-of-Sotatercept-ACE-011-on-Red-Blood-Cell-Mass-and-Plasma-Volume-in-Subjects-Wi/96458/2012-02-01weekly0.1http://trialreach.com/study/Use-of-Clearway-Balloon-vs-Mechanical-Thrombectomy-as-Initial-Treatment-for-Acute-Limb-Ischemia/46120/2012-02-01weekly0.1http://trialreach.com/study/In-Vivo-Dosimetry-During-Prostate-Cancer-Radiotherapy/90994/2012-02-01weekly0.1http://trialreach.com/study/Very-Low-Dose-Caudal-Morphine-for-Postoperative-Pain-Management/17187/2012-02-01weekly0.1http://trialreach.com/study/Hypnosis-For-Hot-Flashes-Among-Postmenopausal-Women-in-a-Randomized-Clinical-Trial/93993/2012-02-01weekly0.1http://trialreach.com/study/Blood-Draw-Study-for-Liver-Transplant-Patients/119340/2012-02-01weekly0.1http://trialreach.com/study/Cortisol-Augmentation-of-a-Psychological-Treatment-in-Warfighters-With-Post-Traumatic-Stress-Disorder-PTSD/103804/2012-02-01weekly0.1http://trialreach.com/study/A-Study-of-ARRY-380-in-Patients-With-Advanced-HER2-Cancer/53210/2012-02-01weekly0.1http://trialreach.com/study/Positron-Emission-Tomography-PET-With-34-dihydroxy-6-18F-fluoro-L-enylalanine-18F-FDOPA-Study/100497/2012-02-01weekly0.1http://trialreach.com/study/Erlotinib-Hydrochloride-and-Radiation-Therapy-in-Stage-III-IV-Squamous-Cell-Cancer-of-the-Head-and-Neck/103708/2012-02-01weekly0.1http://trialreach.com/study/O6-Benzylguanine-and-Topical-Carmustine-in-Early-StageIA-IIA-Cutaneous-T-Cell-Lymphoma/39674/2012-02-01weekly0.1http://trialreach.com/study/Home-Self-Testing-for-HIV-to-Increase-HIV-Testing-Frequency-in-Men-Who-Have-Sex-With-Men-The-iTest-Study/87939/2012-02-01weekly0.1http://trialreach.com/study/Efficacy-Study-of-OPC-34712-in-Adults-With-Acute-Schizophrenia/90808/2012-02-01weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Study-of-SYN115-in-Parkinsons-Patients-Using-Levodopa-to-Treat-End-of-Dose-Wearing-Off/89527/2012-02-01weekly0.1http://trialreach.com/study/Integrated-Treatment-Program-for-Hypochondriasis-in-Primary-Care-Settings/8389/2012-02-01weekly0.1http://trialreach.com/study/ABT-888-and-Topotecan-Hydrochloride-in-Treating-Patients-With-Advanced-Solid-Tumors-or-Relapsed-or-Refractory-Ovarian-Ep/83359/2012-02-01weekly0.1http://trialreach.com/study/Educational-Training-Influence-in-Patients-With-PAHPulmonary-Artery-Hypertension-on-Inhaled-Ventavis-Treatment-Adherence/119387/2012-02-01weekly0.1http://trialreach.com/study/Combined-Modality-Treatment-for-Patients-With-Stage-IV-Melanoma/32082/2012-02-01weekly0.1http://trialreach.com/study/Pharmacokinetics-of-Tenofovir-Emtricitabine-Maraviroc-and-Raltegravir-in-Cervical-Vaginal-and-Rectal-Tissues-and-Secreti/93323/2012-02-01weekly0.1http://trialreach.com/study/Venlafaxine-ER-Phase-3-Study-for-Major-Depressive-Disorder-MDD/119385/2012-02-01weekly0.1http://trialreach.com/study/A-Phase-I-Study-To-Evaluate-The-Antitumor-Activity-And-Safety-Of-AVX901/119389/2012-02-01weekly0.1http://trialreach.com/study/Pegasys-in-Patients-With-Chronic-Myeloid-Leukemia-CML/102946/2012-02-01weekly0.1http://trialreach.com/study/Cardiac-Output-Monitoring-Managing-Intravenous-Therapy-COMMIT-to-Treat-Emergency-Department-Severe-Sepsis/119367/2012-02-01weekly0.1http://trialreach.com/study/Per-Oral-Endoscopic-Myotomy-POEM-for-Treatment-of-Primary-Esophageal-Motility-Disorders/119391/2012-02-01weekly0.1http://trialreach.com/study/Assessment-of-Distal-Protection-Device-in-Patients-at-High-Risk-for-Distal-Embolism-in-Acute-Coronary-Syndrome-ACS/119368/2012-02-01weekly0.1http://trialreach.com/study/A-Phase-1-Clinical-Trial-to-Investigate-Pharmacokinetics-and-Drug-Interaction-of-Crestor-and-Glucodown-OR-SR-in-Healthy-/119369/2012-02-01weekly0.1http://trialreach.com/study/Acceptance-and-Efficacy-of-Live-Supervision/119390/2012-02-01weekly0.1http://trialreach.com/study/Efficacy-and-Safety-Study-of-TA-7284-in-Patients-With-Type-2-Diabetes/106577/2012-02-01weekly0.1http://trialreach.com/study/A-Clinical-Trial-Comparing-the-Combination-of-TC-Plus-Bevacizumab-to-TC-Alone-and-to-TAC-for-Women-With-Node-Positive-or/26518/2012-02-01weekly0.1http://trialreach.com/study/The-Side-of-Implantable-Central-Vascular-Catheters-and-Complications/119372/2012-02-01weekly0.1http://trialreach.com/study/Accelerated-Aging-of-the-Cells-of-Visceral-Adipose-Tissue-in-Morbid-Obese-Subjects/119375/2012-02-01weekly0.1http://trialreach.com/study/Lovazas-Effect-on-Clopidogrel-in-a-Neuro-Population/119386/2012-02-01weekly0.1http://trialreach.com/study/Rituximab-Methotrexate-Vincristine-Sulfate-Procarbazine-Hydrochloride-and-Cytarabine-With-or-Without-Radiation-Therapy-i/99019/2012-02-01weekly0.1http://trialreach.com/study/Can-Hypothermia-be-Incorporated-Into-Primary-Angioplasty-for-Heart-Attack/62608/2012-02-01weekly0.1http://trialreach.com/study/CO2-Insufflation-During-Single-Balloon-Enteroscopy/119370/2012-02-01weekly0.1http://trialreach.com/study/Study-On-Utilization-Of-Cabergoline-For-Compliance-With-Risk-Minimization-Activities-SUCRE/91154/2012-02-01weekly0.1http://trialreach.com/study/A-European-Study-on-Medical-Management-Versus-TAG-Device--Medical-Management-for-Acute-Uncomplicated-Type-B-Dissection/29707/2012-02-01weekly0.1http://trialreach.com/study/Long-Term-Use-Of-Pegaptanib-In-Patients-For-Subfoveal-Choroidal-Neovascularization-Secondary-To-Age-Related-Macular-Dege/23622/2012-02-01weekly0.1http://trialreach.com/study/Hyper-CVAD-Plus-Nelarabine-in-Untreated-T-ALLLymphoblastic-Lymphoma/83495/2012-02-01weekly0.1http://trialreach.com/study/Three-year-Follow-up-Study-of-Subjects-Who-Participated-in-a-Previous-BMS-914143-Chronic-Hepatitis-C-Clinical-Trial/119392/2012-02-01weekly0.1http://trialreach.com/study/Decreasing-the-Use-of-Unmodified-Electroconvulsive-Therapy-ECT-in-an-Indian-Hospital/119395/2012-02-01weekly0.1http://trialreach.com/study/Long-Term-Safety-Study-of-TA-7284-in-Patients-With-Type-2-Diabetes-Mellitus/87448/2012-02-01weekly0.1http://trialreach.com/study/Quality-of-Life-in-Elderly-After-Aneurysmal-Subarachnoid-Hemorrhage-SAH/30763/2012-02-01weekly0.1http://trialreach.com/study/Hygienic-Socks-With-Antifungal-Agent-loaded-Microcapsules-for-Patients-With-Tinea-Pedis/119396/2012-02-01weekly0.1http://trialreach.com/study/Genotype-Guided-Warfarin-Therapy-Trial/46906/2012-02-01weekly0.1http://trialreach.com/study/Effect-of-Glucose-insulin-potassium-Solution-on-Myocardial-Protection-During-Off-pump-Coronary-Bypass-Surgery-in-Patient/93844/2012-02-01weekly0.1http://trialreach.com/study/Haploidentical-Stem-Cell-Transplantation-With-CD3CD19-Depletion-and-Reduced-Intensity-Conditioning-in-Patients-With-Acut/63193/2012-02-01weekly0.1http://trialreach.com/study/Comparative-Efficacy-Research-of-Uni--vs-Bi-lateral-Arm-Training-Poststroke/119397/2012-02-01weekly0.1http://trialreach.com/study/A-Phase-3-Multi-center-Study-to-Assess-PET-Imaging-of-Flurpiridaz-F-18-Injection-in-Patients-With-CAD/100909/2012-02-01weekly0.1http://trialreach.com/study/Study-of-Irinotecan-and-Docetaxel-in-Patients-With-Metastatic-or-Unresectable-Gastric-or-Gastroesophageal-Junction-Adeno/13868/2012-02-01weekly0.1http://trialreach.com/study/Phase-1-Study-of-CEP-37250KHK2804-in-Subjects-With-Advanced-Solid-Tumors/119394/2012-02-01weekly0.1http://trialreach.com/study/Fiber-Longer-Term-Study-on-Energy-Intake/119378/2012-02-01weekly0.1http://trialreach.com/study/Study-of-an-Implantable-Device-for-Lowering-Intraocular-Pressure-in-Glaucoma-Patients-Undergoing-Cataract-Surgery/109079/2012-02-01weekly0.1http://trialreach.com/study/Safety-Study-of-HPP854-in-Subjects-With-Mild-Cognitive-Impairment-or-a-Diagnosis-of-Mild-Alzheimers-Disease/119398/2012-02-01weekly0.1http://trialreach.com/study/Feasibility-of-a-Lateral-Flow-Urine-Lipoarabinomannan-LAM-Test-for-Diagnosis-of-Tuberculosis/119380/2012-02-01weekly0.1http://trialreach.com/study/Cognitive-Assessment-Battery-CAB-Beta-Study/107110/2012-02-01weekly0.1http://trialreach.com/study/Health-related-Quality-of-Life-and-Patient-reported-Outcomes-in-Rheumatoid-Arthritis-Patients-Treated-With-Certolizumab-/119377/2012-02-01weekly0.1http://trialreach.com/study/Bone-Mineral-Density-in-HIV-Patients/112502/2012-01-31weekly0.1http://trialreach.com/study/Carboplatin-Docetaxel-Bevacizumab-and-Erlotinib-Versus-Chemotherapy-Alone-in-Resected-NSCLC/62055/2012-01-31weekly0.1http://trialreach.com/study/RAMSETE-RAD001-in-Advanced-and-Metastatic-Silent-Neuro-endocrine-Tumors-in-Europe/27065/2012-01-31weekly0.1http://trialreach.com/study/Busulfan-Melphalan-Fludarabine-and-T-Cell-Depleted-Allogeneic-Hematopoietic-Stem-Cell-Transplantation-Followed-by-Post-T/102520/2012-01-31weekly0.1http://trialreach.com/study/Placebo-Controlled-Study-of-Preladenant-in-Participants-With-Moderate-to-Severe-Parkinsons-Disease-P07037-AM3/110439/2012-01-31weekly0.1http://trialreach.com/study/Temporal-Artery-Biopsy-vs-ULtrasound-in-Diagnosis-of-GCA-TABUL/74318/2012-01-31weekly0.1http://trialreach.com/study/Ultrasonographic-Differentiation-Between-Kikuchis-Disease-and-Lymphoma-in-Patients-With-Cervical-Lymphadenopathy/90674/2012-01-31weekly0.1http://trialreach.com/study/E7080-in-Combination-With-Dacarbazine-Versus-Dacarbazine-Alone-as-First-Line-Therapy-in-Patients-With-Stage-IV-Melanoma/109771/2012-01-31weekly0.1http://trialreach.com/study/Metformin-in-Obese-Non-diabetic-Pregnant-Women/105918/2012-01-31weekly0.1http://trialreach.com/study/Immunogenicity-and-Safety-of-BoostrixTM-Using-a-New-Syringe-in-10-to-15-year-old-Adolescents/87040/2012-01-31weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-Alendronate-Sodium-Vitamin-D3-Combination-TabletsFOSAMAX-PLUS-Versus-Calcitriol-in-the-Treatment-of-/93100/2012-01-31weekly0.1http://trialreach.com/study/Interprofessional-Training-to-Improve-Diabetes-Care-The-ReSPECT-Trial/57802/2012-01-31weekly0.1http://trialreach.com/study/PDGFR-Inhibitor-Crenolanib-in-ChildrenYoung-Adults-With-Diffuse-Intrinsic-Pontine-Glioma-or-Recurrent-High-Grade-Glioma/105574/2012-01-31weekly0.1http://trialreach.com/study/Obstructive-Sleep-Apnea-Retinal-Vein-Occlusion-Retinal-Artery-Occlusion/86560/2012-01-31weekly0.1http://trialreach.com/study/A-Myeloablative-Conditioning-Regimen-and-Total-Body-Irradiation-Followed-by-the-Transplantation-for-Patients-With-Hemato/7882/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-Strawberries-and-Disease-Risk/88351/2012-01-31weekly0.1http://trialreach.com/study/Prevalence-and-Pathophysiology-of-Sarcopenia-in-the-Elderly-Patient-With-Hip-Fracture/113076/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-F2695-SR-in-Adults-With-Fatigue-Associated-With-Major-Depressive-Disorder/104585/2012-01-31weekly0.1http://trialreach.com/study/Pilot-Study-of-Erlotinib-for-the-Treatment-of-Patients-With-de-Novo-Acute-Myeloid-Leukemia/112180/2012-01-31weekly0.1http://trialreach.com/study/Rapid-Gastric-and-Pancreas-Cancer-Staging-Utilizing-Peritoneal-Lavage/108725/2012-01-31weekly0.1http://trialreach.com/study/Venlafaxine-ER-Long-Term-Extension-Study-for-Major-Depressive-Disorder-MDD/113112/2012-01-31weekly0.1http://trialreach.com/study/Open-Label-Extension-Study-to-810P202/111063/2012-01-31weekly0.1http://trialreach.com/study/Study-of-SAR125844-Single-Agent-Administered-as-Slow-Intravenous-Infusion-in-Adult-Patients-With-Advanced-Malignant-Soli/111308/2012-01-31weekly0.1http://trialreach.com/study/Stem-Cell-Collection-With-Ofatumumab/107601/2012-01-31weekly0.1http://trialreach.com/study/TKI258-for-Metastatic-Inflammatory-Breast-Cancer-Patients/85101/2012-01-31weekly0.1http://trialreach.com/study/Study-Evaluating-The-Use-Of-Sirolimus-In-Recipients-Of-Kidney-Allografts-From-Expanded-Criteria-Donors-ECD/34371/2012-01-31weekly0.1http://trialreach.com/study/A-Multiple-Dose-Study-Of-PF-04950615-In-Subjects-On-Maximum-Doses-Of-Statins/98798/2012-01-31weekly0.1http://trialreach.com/study/A-New-Strategy-Regarding-Discontinuation-of-Dual-Antiplatelet/85266/2012-01-31weekly0.1http://trialreach.com/study/On-Open-Label-Study-in-Participants-With-Systemic-Lupus-Erythematosus/113320/2012-01-31weekly0.1http://trialreach.com/study/A-Randomized-Double-Blind-Controlled-Trial-of-Single-Oral-Dose-Dexamethasone-Versus-Five-Days-of-Oral-Prednisone-in-Acut/106772/2012-01-31weekly0.1http://trialreach.com/study/Nimotuzumab-and-Radiotherapy-in-Pediatric-Patients-With-Glioma/108009/2012-01-31weekly0.1http://trialreach.com/study/A-Safety-and-Efficacy-Study-of-ALPHAGAN-P-and-LUMIGAN-in-Subjects-Previously-Treated-With-Latanoprost-for-Glaucoma-and-O/119266/2012-01-31weekly0.1http://trialreach.com/study/A-Gilead-Sequence-Registry-of-Subjects-Who-Did-Not-Achieve-Sustained-Virologic-Response/112722/2012-01-31weekly0.1http://trialreach.com/study/Study-to-Evaluate-the-Safety-and-Effects-AZD0530-on-Prostate-and-Breast-Cancer-Subjects-With-Metastatic-Bone-Disease/58721/2012-01-31weekly0.1http://trialreach.com/study/Comparison-of-Primary-Long-Full-Coverage-Stenting-vs-Primary-Short-Spot-Stenting-for-Long-Femoropopliteal-Artery-Disease/102331/2012-01-31weekly0.1http://trialreach.com/study/Correlation-of-MR-Thermal-Imaging-to-Actual-Size-of-Ablation-During-Laser-Ablation-Therapy/568/2012-01-31weekly0.1http://trialreach.com/study/Gilead-Sustained-Virologic-Response-SVR-Registry/112748/2012-01-31weekly0.1http://trialreach.com/study/Ranibizumab-in-Residual-Diabetic-Macular-Edema-Following-Previous-Anti-VEGF-Therapy/119304/2012-01-31weekly0.1http://trialreach.com/study/Eribulin-Mesylate-Administered-in-Combination-With-Pemetrexed-Versus-Pemetrexed-Alone-as-Second-Line-Therapy-in-Patients/94651/2012-01-31weekly0.1http://trialreach.com/study/Development-of-a-Versatile-Intra-operative-On-screen-Audiovisual-Mentoring-System-Using-TileproTM-Program-for-Robotic-Ga/94791/2012-01-31weekly0.1http://trialreach.com/study/Nilotinib-800-Mg-And-Imatinib-800-Mg-For-The-Treatment-Of-Patients-With-Gastrointestinal-Stromal-Tumors-Gist-Refractory-/1091/2012-01-31weekly0.1http://trialreach.com/study/Research-and-Evaluation-of-Antipsychotic-Treatment-in-Community-Behavioral-Health-Organizations/111113/2012-01-31weekly0.1http://trialreach.com/study/Veterans-Affairs-Lowering-Readmissions-VALOR-in-Heart-Failure/96175/2012-01-31weekly0.1http://trialreach.com/study/Study-to-Evaluate-the-Efficacy-of-the-Synera-Patch-Compared-to-Naproxen-Sodium-for-Epicondylitis-of-the-Elbow/119275/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Preliminary-Efficacy-Study-of-Mesenchymal-Precursor-Cells-MPCs-in-Subjects-With-Chronic-Discogenic-Lumbar-Bac/106331/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Cabozantinib-XL184-Versus-Mitoxantrone-Plus-Prednisone-in-Men-With-Previously-Treated-Symptomatic-Castration-re/119307/2012-01-31weekly0.1http://trialreach.com/study/Aerobic-Exercise-in-Patients-With-Pulmonary-Hypertension/40652/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-the-Safety-and-Efficacy-of-Two-Different-Regimens-of-Mipomersen-in-Patients-With-Familial-Hypercholesterolemi/119268/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Asenapine-in-the-Prevention-of-Recurrence-of-Mood-Episodes-in-Participants-With-Bipolar-1-Disorde/111311/2012-01-31weekly0.1http://trialreach.com/study/Open-Label-Tolvaptan-Study-in-Subjects-With-ADPKD/85485/2012-01-31weekly0.1http://trialreach.com/study/Atazanavir-Used-in-Combination-With-Other-Anti-HIV-Drugs-in-HIV-Infected-Infants-Children-and-Adolescents/17169/2012-01-31weekly0.1http://trialreach.com/study/A-Safety-and-Efficacy-Study-of-Ciclesonide-Nasal-Aerosol-in-Subjects-6-11-Years-With-Seasonal-Allergic-Rhinitis-SAR/119270/2012-01-31weekly0.1http://trialreach.com/study/A-Trial-Comparing-the-Efficacy-and-Safety-of-Insulin-DegludecLiraglutide-and-Insulin-Degludec-in-Subjects-With-Type-2-Di/96306/2012-01-31weekly0.1http://trialreach.com/study/Gao-Bipolar-Spectrum-LithiumQuetiapine-Study/119316/2012-01-31weekly0.1http://trialreach.com/study/Disulfiram-Combined-With-Lorazepam-for-Alcohol-Dependence-and-Anxiety-Disorder/62296/2012-01-31weekly0.1http://trialreach.com/study/Rectal-Cancer-Local-Staging-Re-staging-and-Assessment-of-Lymph-Nodes-Using-Pet-Ct-CT-Perfusion-and-3T-MRI/119290/2012-01-31weekly0.1http://trialreach.com/study/Evaluating-the-Safety-and-Immune-Response-of-an-Adenovirus-Based-HIV-Vaccine-in-HIV-Uninfected-Adults/106374/2012-01-31weekly0.1http://trialreach.com/study/GemcitabineOxaliplatin-GEMOX-With-or-Without-Erlotinib-Tarceva-in-Advanced-Biliary-Tract-Carcinoma/103592/2012-01-31weekly0.1http://trialreach.com/study/Studies-in-Families-With-Corneal-Dystrophy-or-Other-Inherited-Corneal-Diseases/68927/2012-01-31weekly0.1http://trialreach.com/study/The-Effect-of-Grape-Seed-Extract-on-Blood-Pressure-in-People-With-Pre-Hypertension/65347/2012-01-31weekly0.1http://trialreach.com/study/Tumor-Cell-Vaccines-With-ISCOMATRIXTrademark-Adjuvant-and-Celecoxib-in-Patients-Undergoing-Resection-of-Lung-and-Esophag/98448/2012-01-31weekly0.1http://trialreach.com/study/A-Prospective-Cohort-Study-to-Evaluate-the-Oncotype-DX-Test-in-Early-Stage-Breast-Cancer/112852/2012-01-31weekly0.1http://trialreach.com/study/Nexavar-Versus-Placebo-in-Locally-AdvancedMetastatic-RAI-Refractory-Differentiated-Thyroid-Cancer/76843/2012-01-31weekly0.1http://trialreach.com/study/PURETHAL-Mites-Dose-Range-Finding-Study-in-Patients-With-Persistent-Allergic-RhinitisRhinoconjunctivitis/112815/2012-01-31weekly0.1http://trialreach.com/study/XL-TDR-eXtreme-Lateral-Total-Disc-Replacement-for-the-Treatment-of-Lumbar-Degenerative-Disc-Disease-DDD/3141/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-of-Early-Intensive-ROsuvastatin-Therapy-in-Patients-With-ST-segment-Elevation-Myocardial-Infarction-Undergoing-/111706/2012-01-31weekly0.1http://trialreach.com/study/Studies-of-Acute-Lung-Injury-ALI-and-Acute-Respiratory-Distress-Syndrome/72497/2012-01-31weekly0.1http://trialreach.com/study/Lamivudine-Plus-Adefovir-Versus-Telbivudine-Plus-Adefovir-in-Lamivudine-Resistant-Chronic-Hepatitis-B/94851/2012-01-31weekly0.1http://trialreach.com/study/Impact-of-IntraVascular-UltraSound-Guidance-on-Outcomes-of-Xience-Prime-Stents-in-Long-Lesions-IVUS-XPL-Study/91293/2012-01-31weekly0.1http://trialreach.com/study/A-Study-Of-Two-Dual-PI3KmTOR-Inhibitors-PF-04691502-And-PF-05212384-In-Patients-With-Recurrent-Endometrial-Cancer/119322/2012-01-31weekly0.1http://trialreach.com/study/Digital-Mammography-for-the-Detection-and-Preoperative-Staging-of-Breast-Cancer/100572/2012-01-31weekly0.1http://trialreach.com/study/Study-to-Estimate-the-Burden-of-Herpes-Zoster-and-Postherpetic-Neuralgia-in-Spain/119287/2012-01-31weekly0.1http://trialreach.com/study/Study-to-Evaluate-the-Clinical-Performance-of-the-Valiant-Thoracic-Stent-Graft-With-the-Captivia-Delivery-System-Valiant/103403/2012-01-31weekly0.1http://trialreach.com/study/CREATE-Cross-tumoral-Phase-2-With-Crizotinib/119315/2012-01-31weekly0.1http://trialreach.com/study/AKT-Kinase-Inhibitor-MK-2206-With-Relapsed-Refractory-Acute-Myelogenous-Leukemia/98995/2012-01-31weekly0.1http://trialreach.com/study/PALACE-2-Efficacy-and-Safety-Study-of-Apremilast-to-Treat-Active-Psoriatic-Arthritis/112525/2012-01-31weekly0.1http://trialreach.com/study/Preservation-of-Ovarian-Function-After-Hematopoietic-Cell-Transplant/108831/2012-01-31weekly0.1http://trialreach.com/study/a-Randomized-Multicenter-Trial-Comparing-Vacuum-Assisted-Delivery-With-the-New-Device-iCUP-Versus-the-Reference-Cup/63880/2012-01-31weekly0.1http://trialreach.com/study/Evaluating-Heterologous-Insert-Prime-Boost-HIV-Vaccine-Regimens-in-HIV-Uninfected-Adults/85368/2012-01-31weekly0.1http://trialreach.com/study/Influencing-Adolescent-Girls-With-Creative-Dance-Twice-Weekly/119254/2012-01-31weekly0.1http://trialreach.com/study/An-Open-label-Randomized-Multicenter-Phase-IIIb-Study-to-Assess-the-Efficacy-Safety-and-Tolerance-of-BERIPLEX-PN-Compare/24518/2012-01-31weekly0.1http://trialreach.com/study/IBIS-Italian-Burden-of-Illness-on-Schizophrenia--Bipolar-Disorder/87231/2012-01-31weekly0.1http://trialreach.com/study/PALACE-3-Efficacy-and-Safety-Study-of-Apremilast-to-Treat-Active-Psoriatic-Arthritis/111432/2012-01-31weekly0.1http://trialreach.com/study/Clinical-Trial-of-Simvastatin-to-Treat-Generalized-Vitiligo/119305/2012-01-31weekly0.1http://trialreach.com/study/Eribulin-Mesylate-Administered-in-Combination-With-Gemcitabine-Plus-Cisplatin-Versus-Gemcitabine-Plus-Cisplatin-Alone-as/112148/2012-01-31weekly0.1http://trialreach.com/study/Home-Assessment-and-Initiation-of-Antiretroviral-Therapy-for-HIV-in-Malawi/108060/2012-01-31weekly0.1http://trialreach.com/study/Drug-Interaction-Study-of-Pyronaridine-artesunate-and-Metoprolol-and-Pyronaridine-artesunate-Re-dosing-Study-in-Healthy-/119255/2012-01-31weekly0.1http://trialreach.com/study/Ascending-Multiple-Dose-Study-to-Evaluate-VIA-3196-in-Healthy-Subjects/119327/2012-01-31weekly0.1http://trialreach.com/study/A-Multiple-Dose-Study-of-PF-04950615-in-Subjects-on-High-Doses-of-Statins/89763/2012-01-31weekly0.1http://trialreach.com/study/Subcutaneous-Treatment-In-Randomized-Subjects-To-Evaluate-Safety-And-Efficacy-In-Generalized-Lupus-Erythematosus/107468/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Modified-FOLFIRINOX-in-Advanced-Pancreatic-Cancer/119271/2012-01-31weekly0.1http://trialreach.com/study/Progesterone-Serum-Levels-in-Subfertile-Female-Patients-Undergoing-in-Vitro-Fertilisation-IVF/96024/2012-01-31weekly0.1http://trialreach.com/study/Phase-I-Study-of-Surface-Controlled-Water-Soluble-Curcumin-THERACURMIN-CR-011L/101378/2012-01-31weekly0.1http://trialreach.com/study/Opioid-Induced-Swallowing-Difficulties-and-Risk-for-Pulmonary-Aspiration/119312/2012-01-31weekly0.1http://trialreach.com/study/Phase-III-Further-Retrospect-Clinical-Study-for-FDA-IND-Exemption---Etoposide-and-Single-Nucleotide-Polymorphisms/94513/2012-01-31weekly0.1http://trialreach.com/study/A-Phase-1b2-Multicenter-Randomized-Open-Label-Dose-Escalation-and-Confirmation-Study-of-Eribulin-in-Combination-With-Cap/101185/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Erlotinib-Tarceva-in-Combination-With-OSI-906-in-Patients-With-Advanced-Non-small-Cell-Lung-Cancer-NSCLC-With-A/95724/2012-01-31weekly0.1http://trialreach.com/study/Fluocinolone-Acetonide-Intravitreal-Inserts-for-Vein-Occlusion-in-Retina/84363/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-AC220-Given-After-Transplant-in-Subjects-With-Acute-Myeloid-Leukemia-AML/119258/2012-01-31weekly0.1http://trialreach.com/study/A-Double-Blind-Randomised-Study-Comparing-Hyaluronic-Acid-Corticosteroid-and-Placebo-During-Arthrocentesis-for-Temporoma/119317/2012-01-31weekly0.1http://trialreach.com/study/First-Line-Gemcitabine-Cisplatin--Ipilimumab-for-Metastatic-Urothelial-Carcinoma/119288/2012-01-31weekly0.1http://trialreach.com/study/Fluocinolone-Acetonide-Intravitreal-Inserts-in-Geographic-Atrophy/41214/2012-01-31weekly0.1http://trialreach.com/study/Trial-on-the-Efficacy-of-Tegaderm-Chlorhexidine-Gluconate-CHG-in-Reducing-Catheter-Related-Bloodstream-Infections/100565/2012-01-31weekly0.1http://trialreach.com/study/Effect-of-the-Salbutamol-on-Mechanical-Properties-of-Respiratory-System/119326/2012-01-31weekly0.1http://trialreach.com/study/Isavuconazole-in-the-Treatment-of-Renally-Impaired-Aspergillosis-and-Rare-Fungi/59709/2012-01-31weekly0.1http://trialreach.com/study/Multiple-Ascending-Dose-Study-of-BMS-929075-in-Hepatitis-C-Virus-HCV-Infected-Patients/119310/2012-01-31weekly0.1http://trialreach.com/study/Safety-Tolerability-Pharmacokinetics-and-Pharmacodynamics-Response-of-Vasomera-PB1046-Injection-Following-a-Single-Subcu/119260/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Dalbavancin-for-the-Treatment-of-Acute-Bacterial-Skin-and-Skin-Structure-Infections/104906/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Mitomycin-C-Application-in-Laryngotracheal-Stenosis/119267/2012-01-31weekly0.1http://trialreach.com/study/High-strength-Glass-ionomer-Dental-Restorations/119308/2012-01-31weekly0.1http://trialreach.com/study/A-Window-of-Opportunity-Trial-of-Afatinib-In-Early-Stage-Non-Small-Cell-Lung-Cancer-NSCLC/119283/2012-01-31weekly0.1http://trialreach.com/study/Preventing-Myocardial-Ischemia-by-Preconditioning-in-Elective-Operation-for-Abdominal-Aortic-Aneurysm/119311/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Eslicarbazepine-Acetate-Monotherapy-in-Subjects-With-Partial-Epilepsy-Not-Well-Controlled-by-Curr/648/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Radiation-Exposure-and-Bilateral-Breast-Cancer/70764/2012-01-31weekly0.1http://trialreach.com/study/Extension-Study-of-Asenapine-P06107-NCT01244815-for-Pediatric-Bipolar-Disorder-P05898-AM2/86955/2012-01-31weekly0.1http://trialreach.com/study/Phase-2-Haplotype-Mismatched-HSCT-in-Patients-With-Hematological-Malignancies/46757/2012-01-31weekly0.1http://trialreach.com/study/Extension-Study-in-Subjects-Who-Relapsed-After-Complete-Response-on-Study-KW-0761-001/100948/2012-01-31weekly0.1http://trialreach.com/study/Continuous-Monitoring-of-Lung-Ventilation/69338/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Combined-Therapy-of-Aspirin-and-IVIG-SN-in-Kawasaki-Disease/119292/2012-01-31weekly0.1http://trialreach.com/study/PROlonGed-ExpoSure-Sertraline/119325/2012-01-31weekly0.1http://trialreach.com/study/Ofatumumab-With-or-Without-Bendamustine-for-Patients-With-Mantle-Cell-Lymphoma-Ineligible-for-Autologous-Stem-Cell-Trans/119293/2012-01-31weekly0.1http://trialreach.com/study/Bosentan-for-Treatment-of-Hepatopulmonary-Syndrome-in-Patients-With-Liver-Cirrhosis/119323/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-Chewing-Gum-Snacking-and-Appetite/90418/2012-01-31weekly0.1http://trialreach.com/study/Evaluating-the-Safety-and-Immune-Response-to-an-HIV-Vaccine-Boost-Following-the-Administration-of-Two-HIV-Vaccines-in-HI/119321/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-of-Two-Bolus-Doses-of-Remifentanil-on-the-Incidence-of-Coughing-During-Emergence-of-Anesthesia/119294/2012-01-31weekly0.1http://trialreach.com/study/Non-interventional-Study-on-Oral-Contraception-Not-Containing-Ethinylestradiol-EE-to-Assess-Continuation-Rates-and-Satis/92403/2012-01-31weekly0.1http://trialreach.com/study/Study-of-Association-Between-Maternal-Uric-Acid--Maternal-and-Fetal-Outcome-in-Pregnant-Women-With-Hypertension/119278/2012-01-31weekly0.1http://trialreach.com/study/Vitamin-D-Supplementation-in-HIV-Youth/119318/2012-01-31weekly0.1http://trialreach.com/study/The-Effect-of-the-Timing-of-Postoperative-Mobilisation-After-Locking-Plate-Osteosynthesis-of-Fractures-of-the-Surgical-N/119295/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-of-Parecoxib-on-Patients-With-CRPS/119324/2012-01-31weekly0.1http://trialreach.com/study/Iron-Absorption-in-Vegetarian-Children/119273/2012-01-31weekly0.1http://trialreach.com/study/Cancer-Vaccines-CRS-207-and-GVAX-Pancreas-for-Metastatic-Pancreatic-Adenocarcinoma/119314/2012-01-31weekly0.1http://trialreach.com/study/Comparison-of-Dexmedetomidine-Remifentanil-and-Lidocaine-for-the-Effect-on-Airway-Reflex-and-Hemodynamic-Response-During/90199/2012-01-31weekly0.1http://trialreach.com/study/Isavuconazole-BAL8557-in-the-Treatment-of-Candidemia-and-Other-Invasive-Candida-Infections/67254/2012-01-31weekly0.1http://trialreach.com/study/Photodynamic-Therapy-PDT-Cholangiocarcinoma-Registry/119272/2012-01-31weekly0.1http://trialreach.com/study/Patient-Reported-Outcomes-With-LASIKPROWL-1/119319/2012-01-31weekly0.1http://trialreach.com/study/Dose-Escalation-Study-Using-Ultra-Hypofractionated-Image-Guided-Intensity-Modulated-Radiotherapy-in-Prostate-Cancer/39478/2012-01-31weekly0.1http://trialreach.com/study/A-Safety-and-Efficacy-Study-of-Ciclesonide-Nasal-Aerosol-in-Subjects-6-11-Years-With-Perennial-Allergic-Rhinitis-PAR/119313/2012-01-31weekly0.1http://trialreach.com/study/Improve-the-Treatment-of-Thoracic-Esophageal-Cancer/95385/2012-01-31weekly0.1http://trialreach.com/study/Longitudinal-Study-of-Weight-Change-Following-Lower-Limb-Amputation/19621/2012-01-31weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Effect-of-ASP8597-in-Adult-Kidney-Transplant-Patients/119282/2012-01-31weekly0.1http://trialreach.com/study/International-Prospective-Study-on-Adherence-to-Treatment-in-Patients-With-Active-Systemic-Lupus-Erythematosus/119309/2012-01-31weekly0.1http://trialreach.com/study/Hyperprotein-Nutritional-Intervention-in-Elderly-Patients-With-Hip-Fracture-and-Sarcopenia/110028/2012-01-31weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Safety-Tolerability-Immunogenicity-and-Vaccine-like-Viral-Shedding-of-MEDI-534-Against-Respirato/19793/2012-01-31weekly0.1http://trialreach.com/study/Symptoms-and-Quality-of-Life-QoL-After-Palliative-Pelvic-Radiation-of-Prostate-and-Rectal-Cancers/6856/2012-01-31weekly0.1http://trialreach.com/study/Relevance-of-Plasma-PCSK9-Concentration-as-a-Biomarker-in-Acute-Coronary-Syndrome/92023/2012-01-31weekly0.1http://trialreach.com/study/Study-to-Evaluate-Nilotinib-in-Chronic-Myelogenous-Leukemia-CML-Patients-With-SubOptimal-Response/48951/2012-01-31weekly0.1http://trialreach.com/study/Stem-Cell-Transplantation-for-Patients-With-Multiple-Myeloma/119306/2012-01-31weekly0.1http://trialreach.com/study/A-Trial-on-Video-assisted-Thoracoscopic-Surgery-and-Axillary-Thoracotomy-for-Resection-of-Early-stage-Non-small-Cell-Lun/103100/2012-01-31weekly0.1http://trialreach.com/study/Foley-Catheterization/119320/2012-01-31weekly0.1http://trialreach.com/study/Endostar-andor-Cisplatin-for-Treatment-of-Malignant-Pleural-Effusion-or-Ascites/99702/2012-01-31weekly0.1http://trialreach.com/study/Bendamustine-Hydrochloride-Injection-for-Initial-Treatment-of-Chronic-Lymphocytic-Leukemia/90864/2012-01-31weekly0.1http://trialreach.com/study/Phase-3-IGIV-10-in-Alzheimers-Disease/119257/2012-01-31weekly0.1http://trialreach.com/study/Drug-Interaction-Study-Between-Linezolid-and-Clarithromycin-in-Tuberculosis-Patients/119286/2012-01-31weekly0.1http://trialreach.com/study/Carbon-Monoxide-Therapy-for-Severe-Pulmonary-Arterial-Hypertension/119297/2012-01-31weekly0.1http://trialreach.com/study/Continuous-Endostar-Infusion-Combined-With-Radiotherapy-in-Esophageal-Cancer-Patients/110197/2012-01-31weekly0.1http://trialreach.com/study/CopenHeartRFA---Integrated-Rehabilitation-of-Patients-Treated-for-Atrial-Fibrillation-With-Radio-Frequency-Ablation/119263/2012-01-31weekly0.1http://trialreach.com/study/A-MultiCenter-Study-of-Combined-PEX-Rituximab-and-Steroids-in-Acute-Idiopathic-Pulmonary-Fibrosis-Exacerbations/119298/2012-01-31weekly0.1http://trialreach.com/study/A-Phase-I-Trial-of-Alloreactive-Cell-Infusion-Following-Transplantation-of-Haplotype-Cells-in-Patients-With-Myeloid-Mali/47599/2012-01-31weekly0.1http://trialreach.com/study/Sirolimus-eluting-vs-Zotarolimus-eluting-Stents-for-Chronic-Total-Coronary-Occlusions/40717/2012-01-31weekly0.1http://trialreach.com/study/A-Randomized-Controlled-Trial-to-Determine-Outcome-and-Cost-Effectiveness-of-Case-Management-of-Chronic-Obstructive-Pulm/119251/2012-01-31weekly0.1http://trialreach.com/study/Prospective-Longitudinal-Multicentric-Survey-in-the-Therapeutic-Care-of-Mild-to-Moderate-Ulcerative-Colitis/87216/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-Neoadjuvant-Photodynamic-Immunomodulation-for-Colon-Cancer/119299/2012-01-31weekly0.1http://trialreach.com/study/A-Two-dose-Level-Clinical-Trial-of-Itraconazole-in-Patients-With-Metastatic-Prostate-Cancer-Who-Have-Had-Disease-Progres/40683/2012-01-31weekly0.1http://trialreach.com/study/Development-of-a-City-Wide-Cohort-of-HIV-Infected-Persons-in-Care-in-the-District-of-Columbia-The-DC-Cohort/96828/2012-01-31weekly0.1http://trialreach.com/study/Study-of-the-Brutons-Tyrosine-Kinase-Inhibitor-in-Subjects-With-Relapsed-or-Relapsed-and-Refractory-Multiple-Myeloma/119265/2012-01-31weekly0.1http://trialreach.com/study/Proton-Stereotactic-Body-Radiation-Therapy-for-Early-Stage-Non-Small-Cell-Lung-Cancer/119284/2012-01-31weekly0.1http://trialreach.com/study/Effect-of-Laser-Use-on-Guided-Tissue-Regeneration-in-Treatment-of-Molar-Teeth-With-Class-2-Furcation-Affected-by-Periodo/119261/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Recombinant-Von-Willebrand-Factor-rVWF-in-the-Treatment-and-Prevention-of-Bleeding-Episodes-in-Vo/92999/2012-01-31weekly0.1http://trialreach.com/study/Pharmacological-Clinical-and-Statistical-Assessment-of-a-New-Tool-Available-for-Pharmacodependence-Report-Evaluation/69328/2012-01-31weekly0.1http://trialreach.com/study/Preventing-Aggression-in-Veterans-With-Dementia/99160/2012-01-31weekly0.1http://trialreach.com/study/Donor-Peripheral-Stem-Cell-Transplant-in-Treating-Patients-With-Hematolymphoid-Malignancies/119256/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-Pemetrexed-and-Bevacizumab-for-Patients-With-Advanced-Non-Small-Cell-Cancer/30902/2012-01-31weekly0.1http://trialreach.com/study/Pilot-Study-of-Hyperthermic-Peritoneal-Perfusion-HIPEC-for-Adolescent-and-Young-Adults-With-Desmoplastic-Small-Round-Cel/98245/2012-01-31weekly0.1http://trialreach.com/study/Pharmacodynamic-of-Ceftaroline-and-Levofloxacin-Against-Pathogens-Associated-With-Community-Acquired-Bacterial-Pneumonia/119274/2012-01-31weekly0.1http://trialreach.com/study/Topical-Local-Anaesthesia-and-Cooling-During-Capsaicin-8-Patch-Application/119300/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Study-of-HER2Neu-E75-Vaccine-in-Node-Positive-Breast-Cancer-Patients/119252/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Chlorthalidone--Amiloride-to-Elderly-Patients-Treatment-With-Arterial-Hypertension/109644/2012-01-31weekly0.1http://trialreach.com/study/Intra-nasal-Challenge-of-Healthy-Adults-With-Respiratory-Syncytial-Virus-RSV/119281/2012-01-31weekly0.1http://trialreach.com/study/The-Effects-of-Chronic-Exposure-to-Low-Level-Blasts/119264/2012-01-31weekly0.1http://trialreach.com/study/Ruxolitinib-INCB018424-in-Subjects-With-Primary-Myelofibrosis-Post-Essential-Thrombocythemia-myelofibrosis-and-Post-Poly/105536/2012-01-31weekly0.1http://trialreach.com/study/A-Study-Of-The-Efficacy-And-Safety-Of-Sunitinib-In-Patients-With-Advanced-Well-Differentiated-Pancreatic-Neuroendocrine-/119253/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-VIVITROL-in-the-Prevention-of-Re-arrest-and-Re-incarceration/119276/2012-01-31weekly0.1http://trialreach.com/study/The-Effect-of-Intravenous-Lidocaine-on-Post-extubation-Laryngospasm/119279/2012-01-31weekly0.1http://trialreach.com/study/Collateral-Ventilation-Effects-on-Response-to-AeriSeal-System-Treatment-in-Upper-Lobe-Predominant-Emphysema/119280/2012-01-31weekly0.1http://trialreach.com/study/Study-Evaluating-A-Planned-Transition-From-Tacrolimus-To-Sirolimus-In-Kidney-Transplant-Recipients/4231/2012-01-31weekly0.1http://trialreach.com/study/A-Phase-1-Study-of-Dexanabinol-in-Patients-With-Advanced-Solid-Tumours/119285/2012-01-31weekly0.1http://trialreach.com/study/Live-Lung-Donor-Cross-sectional-Cohort-Study/119289/2012-01-31weekly0.1http://trialreach.com/study/Evaluation-of-Branch-Endografts-in-the-Treatment-of-Aortic-Aneurysms/119291/2012-01-31weekly0.1http://trialreach.com/study/Talent-Converter-Post-Approval-Study/96522/2012-01-31weekly0.1http://trialreach.com/study/Evaluation-of-AGN-150998-in-Exudative-Age-related-Macular-Degeneration-AMD/105323/2012-01-31weekly0.1http://trialreach.com/study/Topical-Application-of-Tranexamic-Acid-to-Reduce-Post-operative-Bleeding-in-Coronary-Artery-Bypass-Surgery/119296/2012-01-31weekly0.1http://trialreach.com/study/Irinotecan-Plus-Lenalidomide-in-Adult-Patients-With-Recurrent-Glioblastoma-Multiforme/69481/2012-01-31weekly0.1http://trialreach.com/study/A-Comparative-Study-of-Robotic-Thyroidectomy-Using-Transaxillary-Approach-Versus-Conventional-Open-Thyroidectomy/88914/2012-01-31weekly0.1http://trialreach.com/study/A-Study-of-LY2623091-in-Male-and-Females-With-Chronic-Kidney-Disease/119301/2012-01-31weekly0.1http://trialreach.com/study/Trial-for-Vaccine-Therapy-With-Dendritic-Cells-in-Patients-With-Metastatic-Malignant-Melanoma/74187/2012-01-31weekly0.1http://trialreach.com/study/Surgical-Site-Infection-Study/119277/2012-01-31weekly0.1http://trialreach.com/study/Immune-Mediated-Disorders-After-Allogeneic-Hematopoietic-Cell-Transplantation/99120/2012-01-31weekly0.1http://trialreach.com/study/AVE8062-in-Combination-With-Platinum-taxane-Doublet-in-Advanced-Solid-Tumor/57494/2012-01-31weekly0.1http://trialreach.com/study/Posaconazole-Versus-Micafungin-for-Prophylaxis-Against-Invasive-Fungal-Infections-During-Neutropenia-in-Patients-Undergo/108658/2012-01-31weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Study-of-Bimatoprost-in-the-Treatment-of-Women-With-Female-Pattern-Hair-Loss/112309/2012-01-31weekly0.1http://trialreach.com/study/Antimicrobial-Stewardship-Through-MRSA-Diagnosis-in-Emergency-Department-ED-Patients-With-Abscesses/119269/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-and-Safety-Study-of-the-Combined-Modality-Therapy-in-Adenocarcinoma-of-the-Esophago-gastric-Junction/119262/2012-01-31weekly0.1http://trialreach.com/study/A-Safety-and-Efficacy-Study-of-Oral-MDV3100-in-Chemotherapy-Naive-Patients-With-Progressive-Metastatic-Prostate-Cancer/99810/2012-01-31weekly0.1http://trialreach.com/study/Isavuconazole-BAL8557-for-Primary-Treatment-of-Invasive-Aspergillosis/67201/2012-01-31weekly0.1http://trialreach.com/study/Effectiveness-Study-of-Community-Based-Peer-Led-Education-on-Weight-Loss-and-Diabetes/20755/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Dalbavancin-for-the-Treatment-of-Acute-Bacterial-Skin-and-Skin-Structure-Infections/119259/2012-01-31weekly0.1http://trialreach.com/study/Efficacy-and-Safety-Dose-Finding-Study-of-Givinostat-to-Treat-Polyarticular-Course-Juvenile-Idiopathic-Arthritis/108992/2012-01-31weekly0.1http://trialreach.com/study/Diffusion-Tensor-Imaging-DTI-in-Infants-With-Krabbe-Disease/49708/2012-01-31weekly0.1http://trialreach.com/study/EUS-Guided-ERCP-Multicenter-Registry/119302/2012-01-31weekly0.1http://trialreach.com/study/Treatment-of-Older-Veterans-With-Chronic-Posttraumatic-Stress-Disorder/39375/2012-01-31weekly0.1http://trialreach.com/study/An-Open-Label-2-Cohort-Multicenter-Study-of-E7080-in-Previously-Treated-Subjects-With-Unresectable-Stage-III-or-Stage-IV/101073/2012-01-31weekly0.1http://trialreach.com/study/Natural-Versus-HRT-Cycles-in-Frozen-Embryo-Replacement-Treatment/45926/2012-01-31weekly0.1http://trialreach.com/study/VA-NEPHRON-D-Diabetes-iN-Nephropathy-Study/6452/2012-01-31weekly0.1http://trialreach.com/study/The-National-Oncologic-PET-Registry/49280/2012-01-31weekly0.1http://trialreach.com/study/Vaccination-Against-Influenza-in-Autoimmune-Diseases/95183/2012-01-31weekly0.1http://trialreach.com/study/Post-Market-Registry-Study-of-the-AeriSeal-System/119303/2012-01-31weekly0.1http://trialreach.com/study/Comparative-Efficacy-and-Safety-Study-in-Patients-With-Active-Ulcerative-Colitis/93929/2012-01-30weekly0.1http://trialreach.com/study/Trial-of-Two-Stem-Cell-Doses-To-Reduce-Transplant-Induced-Symptom-Burden/15373/2012-01-30weekly0.1http://trialreach.com/study/Fit-Over-45---a-Health-Promotion-Project-for-Inactive-Female-Hospital-Staff-Age-45-From-the-University-Hospital-of-Zrich/78123/2012-01-30weekly0.1http://trialreach.com/study/Therapeutic-Research-in-Multiple-Myeloma/32467/2012-01-30weekly0.1http://trialreach.com/study/RAD001-in-Recurrent-Endometrial-Cancer-Patients/9968/2012-01-30weekly0.1http://trialreach.com/study/Dysport-Adult-Upper-Limb-Spasticity-Extension-Study/86693/2012-01-30weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Ypeginterferon-Alfa-2b-in-HBeAg-Positive-Chronic-Hepatitis-B/93959/2012-01-30weekly0.1http://trialreach.com/study/Open-Label-Study-of-the-Long-Term-Safety-of-Pirfenidone-in-Patients-With-Idiopathic-Pulmonary-Fibrosis-IPF/27958/2012-01-30weekly0.1http://trialreach.com/study/rhGH-and-rhIGF-1-Combination-Therapy-in-Children-With-Short-Stature-Associated-With-IGF-1-Deficiency/30792/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Effectiveness-of-Arcuate-Incisions-Performed-With-the-iFS-Femtosecond-Laser-System/107059/2012-01-30weekly0.1http://trialreach.com/study/Safety-Study-of-Pb-TCMC-Trastuzumab-Radio-Immunotherapy/93589/2012-01-30weekly0.1http://trialreach.com/study/EFA-Nutrition-1-2-Yr-Olds/92291/2012-01-30weekly0.1http://trialreach.com/study/Alemtuzumab-Fludarabine-Phosphate-and-Total-Body-Irradiation-Followed-by-Cyclosporine-and-Mycophenolate-Mofetil-in-Treat/10412/2012-01-30weekly0.1http://trialreach.com/study/A-Long-term-Observational-Study-Cohort-in-Patients-With-Advanced-Prostate-Cancer/87224/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-PK-Study-of-RRx-001-in-Cancer-Subjects/107979/2012-01-30weekly0.1http://trialreach.com/study/Repetitive-Transcranial-MAgnetic-STimulation-rTMS-for-MotoR-and-Mood-Symptoms-of-Parkinsons-Disease-MASTER-PD-a-Multicen/111802/2012-01-30weekly0.1http://trialreach.com/study/Equivalence-of-Intramuscular-IM-Versus-Subcutaneous-SC-Applications-of-Long-Acting-Pamorelin-1125-mg/84967/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-Doripenem-in-Infants-Less-Than-12-Weeks-of-Age/87186/2012-01-30weekly0.1http://trialreach.com/study/Usability-and-Tolerability-of-the-Norditropin-NordiFlex-Injection-Device-in-Children-Never-Previously-Treated-With-Growt/94661/2012-01-30weekly0.1http://trialreach.com/study/Safety-Tolerability-Pharmacokinetics-and-Pharmacodynamics-Study-of-Pegylated-Somatropin-in-Healthy-Volunteers/88938/2012-01-30weekly0.1http://trialreach.com/study/Autologous-Stem-Cell-Rescue-With-CD133-Selected-Cells-in-High-Risk-Neuroblastoma/48707/2012-01-30weekly0.1http://trialreach.com/study/Early-Prediction-of-Therapeutic-Response-to-Targeted-Therapy-in-Stage-IIIBIV-or-Recurrent-Lung-Cancer-Patients/3114/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-MEDI-575-in-Subjects-With-Recurrent-Glioblastoma-Multiforme/105312/2012-01-30weekly0.1http://trialreach.com/study/Light-Therapy-in-the-Treatment-of-the-Acute-Phase-of-the-Bipolar-Type-II-Depression/47391/2012-01-30weekly0.1http://trialreach.com/study/2CDA-With-Rituximab-in-Hairy-Cell-Leukemia/51006/2012-01-30weekly0.1http://trialreach.com/study/The-Treatment-of-Tinnitus-With-Transcutaneous-Non-invasive-Vagus-Nerve-Stimulation/105387/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-the-Safety-and-Efficacy-of-a-New-Treatment-for-Diabetic-Macular-Edema/11724/2012-01-30weekly0.1http://trialreach.com/study/Evaluation-of-Multiscore-Feedback-in-Professionalism-for-Anesthesia/119241/2012-01-30weekly0.1http://trialreach.com/study/Chemoradiation-Gemcitabine-Continuous-5-FU-Fluorouracil-Followed-by-High-Dose-BrachytherapyStereotactic-Radiation-Boost-/59481/2012-01-30weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Ypeginterferon-Alfa-2b-in-Chronic-Hepatitis-C/109597/2012-01-30weekly0.1http://trialreach.com/study/Returning-to-Work-Efficacy-of-Tailored-Physical-Activity-or-Chronic-Pain-Self-management-Program-in-Sicklisted-Citizens-/107190/2012-01-30weekly0.1http://trialreach.com/study/A-Trial-of-Ferumoxytol-for-the-Treatment-of-Iron-Deficiency-Anemia/92616/2012-01-30weekly0.1http://trialreach.com/study/Evaluation-of-Relapse-Efficacy-and-Safety-of-Long-term-Treatment-With-Oracea-vs-Placebo-After-12-Weeks-of-Oracea-and-Met/112850/2012-01-30weekly0.1http://trialreach.com/study/Hybrid-Immunotherapy-for-Hemophagocytic-LymphoHistiocytosis/88058/2012-01-30weekly0.1http://trialreach.com/study/Lymphodepletion-Plus-Adoptive-Cell-Transfer-With-High-Dose-IL-2-in-Patients-With-Metastatic-Melanoma/40988/2012-01-30weekly0.1http://trialreach.com/study/GeneXpert-MTBRif-a-New-Tool-for-the-Diagnosis-of-Pulmonary-Tuberculosis-in-Two-Municipalities-in-Brazil/88165/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Immunogenicity-in-Adults-of-Revaccination-With-Adacel-Vaccine-10-Years-After-a-Previous-Dose/112881/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Evaluation-of-Two-Year-Imatinib-Treatment-in-Adjuvant-Gastrointestinal-Stromal-Tumor-GIST/110319/2012-01-30weekly0.1http://trialreach.com/study/Involvement-of-Transverso-sacral--Neo--Articulations-or-of-Transverso-iliac-Articulations-in-Chronic-Lumbago/95272/2012-01-30weekly0.1http://trialreach.com/study/Blood-Glucose-Control-in-Intensive-Care-Patients-Using-the-Space-GlucoseControl-System/119244/2012-01-30weekly0.1http://trialreach.com/study/Autologous-Vaccine-for-Follicular-Lymphoma/31113/2012-01-30weekly0.1http://trialreach.com/study/Pazopanib-and-Vinflunine-in-Urothelial-Cancer-of-the-Bladder/98641/2012-01-30weekly0.1http://trialreach.com/study/Decitabine-Maintenance-in-Elderly-Acute-Myeloid-Leukemia-Patients/96098/2012-01-30weekly0.1http://trialreach.com/study/A-Dose-Escalation-Study-in-Participants-With-Advanced-Cancer/119247/2012-01-30weekly0.1http://trialreach.com/study/Multi-Beam-Intensity-Modulated-Radiation-Therapy-for-Node-Positive-Breast-Cancer/89446/2012-01-30weekly0.1http://trialreach.com/study/Fluorodeoxyglucose-FDG-Positron-Emission-Tomography-PET-in-Cancer-Associated-Venothromboembolism/88965/2012-01-30weekly0.1http://trialreach.com/study/A-Phase-3-Study-of-Brentuximab-Vedotin-SGN-35-in-Patients-at-High-Risk-of-Residual-Hodgkin-Lymphoma-Following-Stem-Cell-/95021/2012-01-30weekly0.1http://trialreach.com/study/A-Phase-2-Study-of-BTA798-in-Asthmatic-Adults-With-Symptomatic-Human-Rhinovirus-Infection/94043/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-Pyridostigmine-in-Postural-Tachycardia-Syndrome/75210/2012-01-30weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Efficacy-and-Safety-of-IV-Peramivir-in-Addition-to-Standard-of-Care-Compared-to-Standard-of-Care/46664/2012-01-30weekly0.1http://trialreach.com/study/Growth-Hormone-Cardiovascular-Risk-and-Visceral-Adiposity/35176/2012-01-30weekly0.1http://trialreach.com/study/NEP-TUNE-Neuropathic-Pain---Treatment-With-Pregabalin-Under-Real-life-Conditions-in-Denmark/119246/2012-01-30weekly0.1http://trialreach.com/study/RAD001-FOLFOX-and-Bevacizumab-in-Treatment-of-Colorectal-Carcinoma/29159/2012-01-30weekly0.1http://trialreach.com/study/Bevacizumab-Cetuximab-and-Cisplatin-With-IMRT-Intensity-Modulated-Radiation-Therapy-for-Patients-With-Stage-IIIIV-Head-a/6013/2012-01-30weekly0.1http://trialreach.com/study/Wireless-Stimulation-Endocardially-for-Cardiac-Resynchronization-Therapy/93563/2012-01-30weekly0.1http://trialreach.com/study/Tenofovir-in-Chronic-Hepatitis-B-With-Mild-ALT-Elevation/119243/2012-01-30weekly0.1http://trialreach.com/study/Effect-of-Early-vs-Late-Drainage-Removal-in-Women-After-Radical-Mastectomy-With-Axillary-Clearance/112217/2012-01-30weekly0.1http://trialreach.com/study/Nab-paclitaxel-Gemcitabine-and-Bevacizumab-in-Advanced-Malignancies/111724/2012-01-30weekly0.1http://trialreach.com/study/Study-of-FX005-for-the-Treatment-of-Pain-in-Patients-With-Osteoarthritis-of-the-Knee/101196/2012-01-30weekly0.1http://trialreach.com/study/Lidocaine-Subcutaneous-Infusion-for-Control-of-Treprostinil-Related-Site-Pain/119249/2012-01-30weekly0.1http://trialreach.com/study/A-Study-to-Assess-Selected-Biomarkers-in-Subjects-Requiring-Daily-Inhaled-Corticosteroids-for-Persistent-Asthma/97829/2012-01-30weekly0.1http://trialreach.com/study/Vitamin-D-in-Vulnerable-Adults-VIVA-VA/110797/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Study-in-Subjects-With-Leber-Congenital-Amaurosis/82122/2012-01-30weekly0.1http://trialreach.com/study/Safety-Study-of-HPP593-in-Subjects-During-and-After-Limb-Immobilization/119238/2012-01-30weekly0.1http://trialreach.com/study/Safety-Tolerability-and-Pharmacodynamic-Activity-of-JNJ-26528398-in-Healthy-Male-Participants/119169/2012-01-30weekly0.1http://trialreach.com/study/Combined-Behavioral-Approaches-With-Functional-Electrical-Therapy-in-Stroke-Rehabilitation/119248/2012-01-30weekly0.1http://trialreach.com/study/A-Prospective-Multicenter-Clinical-Study-to-Evaluate-the-Safety-and-Effectiveness-of-the-Synchrony-Dual-Optic-Intraocula/37311/2012-01-30weekly0.1http://trialreach.com/study/Geriatric-Assessment-and-Nursing-Telephone-Intervention-in-Elderly-Women-With-Ovarian-Cancer/119236/2012-01-30weekly0.1http://trialreach.com/study/Context---Remote-Ischemic-Conditioning-in-Renal-Transplantation---Effect-on-Immediate-and-Extended-Kidney-Graft-Function/102253/2012-01-30weekly0.1http://trialreach.com/study/Trial-of-Low-and-High-Intensity-Strategies-to-Maintain-BP-Control/31283/2012-01-30weekly0.1http://trialreach.com/study/Study-of-Treatment-With-Nilotinib-in-Adult-Patients-With-Imatinib---Resistant-or---Intolerant-Chronic-Myeloid-Leukemia-i/69093/2012-01-30weekly0.1http://trialreach.com/study/Study-to-Evaluate-the-Safety-and-Efficacy-of-IV-Infusion-Treatment-With-Omecamtiv-Mecarbil-in-Subjects-With-Left-Ventric/108053/2012-01-30weekly0.1http://trialreach.com/study/Dysport-Adult-Upper-Limb-Spasticity/108105/2012-01-30weekly0.1http://trialreach.com/study/SB1518-for-Patients-With-Myelodysplastic-Syndrome-MDS/119237/2012-01-30weekly0.1http://trialreach.com/study/Tamoxifen-Versus-Anastrozole-Alone-or-in-Combination-With-Zoledronic-Acid/83838/2012-01-30weekly0.1http://trialreach.com/study/Repeating-Patterns-of-Sleep-Restriction-and-Recovery/119239/2012-01-30weekly0.1http://trialreach.com/study/One-Year-Follow-up-of-Study-2-79-52030-207-PRIMARYS-in-Acromegalic-Patients-With-Macroadenoma/119201/2012-01-30weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Effectiveness-of-a-Drug-MEDI-563-in-Subjects-With-Chronic-Obstructive-Pulmonary-Disease-COPD/96127/2012-01-30weekly0.1http://trialreach.com/study/A-Study-Examining-the-Effects-of-Nebivolol-Compared-to-Atenolol-on-Endothelial-Function/119199/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Liraglutide-in-Combination-With-an-OAD-in-Subjects-With-Type-2-Diabetes-Insufficiently-Controlled/119240/2012-01-30weekly0.1http://trialreach.com/study/Early-Immune-Responses-to-Inactivated-Influenza-Vaccine-a-Pilot-Study/119181/2012-01-30weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-GS-6624-With-FOLFIRI-as-Second-Line-Treatment-in-Colorectal-Adenocarcinoma/119245/2012-01-30weekly0.1http://trialreach.com/study/Study-to-Assess-the-Tolerability-and-Efficacy-of-Anacetrapib-Co-administered-With-Statin-in-Participants-With-Heterozygo/119215/2012-01-30weekly0.1http://trialreach.com/study/Study-Evaluating-the-Safety-and-Efficacy-of-FOLFIRI-Plus-Cetuximab-Erbitux-or-FOLFOX-Plus-Cetuximab-as-First-line-Therap/2794/2012-01-30weekly0.1http://trialreach.com/study/Multi-Tracer-PET-Assessment-of-Primary-Brain-Tumors/80360/2012-01-30weekly0.1http://trialreach.com/study/Safety-Study-of-NNZ-2566-in-Healthy-Subjects-Following-Oral-Administration/119242/2012-01-30weekly0.1http://trialreach.com/study/Afatinib-BIBW-2992-in-Patients-With-Advanced-HER2-Positive-Trastuzumab-Refractory-Advanced-Esophagogastric-Cancer/119189/2012-01-30weekly0.1http://trialreach.com/study/Effects-of-Intravenous-IV-Citalopram-on-Emotional-Brain-Activity-in-Healthy-Young-and-Elderly-Adults/92209/2012-01-30weekly0.1http://trialreach.com/study/Sirolimus-and-Cetuximab-in-Advanced-Malignancies/47331/2012-01-30weekly0.1http://trialreach.com/study/Observational-Program-of-Zemplar-in-Patients-With-End-Stage-Chronic-Kidney-Disease-and-Parathyroid-Disorder-on-Hemodialy/96164/2012-01-30weekly0.1http://trialreach.com/study/Complications-Urgent-C-Section-VS-Elective-C-Section/119190/2012-01-30weekly0.1http://trialreach.com/study/IGFD-Registry-A-Patient-Registry-for-Monitoring-Long-term-Safety-and-Efficacy-of-Increlex/38599/2012-01-30weekly0.1http://trialreach.com/study/Characterization-of-the-Changes-in-the-Signalling-Pathways-During-Spinal-Cord-Injury-induced-Skeletal-Muscle-Atrophy/119174/2012-01-30weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Extended-Release-ER-NiacinLaropiprant-When-Added-to-Ongoing-Lipid-Modifying-Therapy-in-Patients-W/111664/2012-01-30weekly0.1http://trialreach.com/study/Proton-Radiotherapy-for-Recurrent-Tumors/91857/2012-01-30weekly0.1http://trialreach.com/study/Phase-II-Trial-of-Erlotinib-Prior-to-Surgery-or-Radiation-in-Patients-With-Squamous-Cell-Cancers-SCC-of-the-Skin/64724/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Study-of-IPG-Patient-With-Home-Monitoring/119171/2012-01-30weekly0.1http://trialreach.com/study/Efficacy--Safety-Comparison-of-Epiduo-With-Doxycycline-Versus-Vehicle-With-Isotretinoin-in-the-Treatment-of-Severe-Acne/119250/2012-01-30weekly0.1http://trialreach.com/study/Arterial-Spin-Labeling-Perfusion-Magnetic-Resonance-MR-Imaging-in-Pediatric-Brain-Tumors/82981/2012-01-30weekly0.1http://trialreach.com/study/A-Randomized-Controlled-Study-to-Assess-the-Effects-of-Bisoprolol-and-Atenolol-on-Resting-Heart-Rate-and-Sympathetic-Ner/102846/2012-01-30weekly0.1http://trialreach.com/study/European-Increlex-Mecasermin-rDNA-Origin-Injection-Growth-Forum-Database---IGFD-Registry/81914/2012-01-30weekly0.1http://trialreach.com/study/Effect-of-Carbohydrates-From-Nutritional-Beverages-in-Children/87410/2012-01-30weekly0.1http://trialreach.com/study/Fludarabine-Mitoxantrone-and-Dexamethasone-FND-Plus-Rituximab-for-Lymphoma-Patients/6342/2012-01-30weekly0.1http://trialreach.com/study/Study-to-Observe-Safety-of-Xarelto-in-VTE-Prophylaxis-After-Elective-TKR-or-THR/119209/2012-01-30weekly0.1http://trialreach.com/study/Effects-of-Home-based-Pulmonary-Rehabilitation-in-Patients-With-Severe-or-Very-Severe-Chronic-Obstructive-Pulmonary-Dise/93786/2012-01-30weekly0.1http://trialreach.com/study/A-Phase-II-Uncontrolled-Study-of-BAY73-4506-in-Previously-Untreated-Patients-With-Metastatic-or-Unresectable-RCC/60535/2012-01-30weekly0.1http://trialreach.com/study/Caudal-Versus-Rectus-Sheath-Study/110831/2012-01-30weekly0.1http://trialreach.com/study/Phase-II-Study-of-Crenolanib-in-Subjects-With-Relapsed-AML-With-FLT3-D835-Activating-Mutations/119185/2012-01-30weekly0.1http://trialreach.com/study/Study-of-Dovitinib-TKI258-in-Adenoid-Cystic-Carcinoma/119210/2012-01-30weekly0.1http://trialreach.com/study/Study-to-Assess-the-Efficacy-of-Brachytherapy-With-or-Without-Hormone-Therapy-Using-Triptorelin-225mg-in-Patients-With-R/110614/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-the-HSP90-Inhibitor-AUY922/119193/2012-01-30weekly0.1http://trialreach.com/study/Yervoy-With-Sylatron-Unresectable-Stage-3-or-4-Melanoma/119191/2012-01-30weekly0.1http://trialreach.com/study/The-VMVN-Study-Virological-Monitoring-in-Viet-Nam/108772/2012-01-30weekly0.1http://trialreach.com/study/Risk-Factors-for-Anal-Sphincter-Damage-During-Vaginal-Delivery/94077/2012-01-30weekly0.1http://trialreach.com/study/Predictive-Value-of-the-Insulin-like-Growth-Factor-1-IGF-1-Generation-Test-for-the-Growth-Response-to-Growth-Hormone-Tre/119214/2012-01-30weekly0.1http://trialreach.com/study/Clinical-Trial-Comparing-Outcomes-of-Breast-Conserving-Operations-With-Classic-v-High-frequency-Electrocoagulation/97033/2012-01-30weekly0.1http://trialreach.com/study/A-Norwegian-Observational-Trial-Evaluating-the-Treatment-of-Advanced-Renal-Cell-Cancer-Patients-Under-Treatment-of-Afini/102725/2012-01-30weekly0.1http://trialreach.com/study/A-Canadian-Multi-centre-Observational-Registry-to-Study-Adherence-and-Long-Term-Outcomes-of-Therapy-in-Pediatric-Subject/85149/2012-01-30weekly0.1http://trialreach.com/study/Adult-Subjects-Suffering-From-Lower-Limb-Spasticity-Following-Stroke/119175/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Ipamorelin-Compared-to-Placebo-for-the-Recovery-of-Gastrointestinal-Function/98593/2012-01-30weekly0.1http://trialreach.com/study/Care-Partners-Web-based-Support-for-Caregivers-of-Veterans-Undergoing-Chemotherapy/21550/2012-01-30weekly0.1http://trialreach.com/study/A-Phase-1-Study-of-Brentuximab-Vedotin-Given-Sequentially-and-Combined-With-Multi-Agent-Chemotherapy-for-CD30-Positive-M/90179/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-the-Safety-and-Efficacy-of-a-New-Treatment-for-Diabetic-Macular-Edema/7706/2012-01-30weekly0.1http://trialreach.com/study/An-Efficacy-and-Safety-Study-of-Somatuline-Depot-Lanreotide-Injection-to-Treat-Carcinoid-Syndrome/25711/2012-01-30weekly0.1http://trialreach.com/study/Carmustine-Etoposide-Cytarabine-Melphalan-and-Antithymocyte-Globulin-Followed-by-Peripheral-Blood-Stem-Cell-Transplant-i/18878/2012-01-30weekly0.1http://trialreach.com/study/F-18-Fluorothymidine-FLT-Imaging-on-Patients-With-Primary-Brain-Tumors/58503/2012-01-30weekly0.1http://trialreach.com/study/SPD503-in-Subjects-Aged-6-17-Years-With-Generalized-Anxiety-Disorder-GAD-Separation-Anxiety-Disorder-SAD-or-Social-Phobi/119224/2012-01-30weekly0.1http://trialreach.com/study/Craniofacial-Surgery-Perioperative-Registry/19778/2012-01-30weekly0.1http://trialreach.com/study/Efficacy-Safety-Tolerability-and-Pharmacokinetics-of-KAE609-in-Adult-Patients-With-Acute-Uncomplicated-Plasmodium-Falcip/119223/2012-01-30weekly0.1http://trialreach.com/study/Study-of-the-Safety-and-Efficacy-of-ATS907-in-Subjects-With-Primary-Open-Angle-Glaucoma-POAG-and-Ocular-Hypertension/119211/2012-01-30weekly0.1http://trialreach.com/study/Clinical-Evaluation-of-Ajust-in-Stress-Urinary-Incontinence/86546/2012-01-30weekly0.1http://trialreach.com/study/A-Clinical-Study-of-Trazodone-Hydrochloride-Prolonged-Release-Tablets-for-Treatment-of-Depression/119195/2012-01-30weekly0.1http://trialreach.com/study/Quantitative-Measurement-of-Cardiopulmonary-Resuscitation-CPR-During-In-Hospital-Cardiac-Arrest/3558/2012-01-30weekly0.1http://trialreach.com/study/Diet-and-Exercise-in-Type-2-Diabetes---a-Randomized-Controlled-Trial/119213/2012-01-30weekly0.1http://trialreach.com/study/Shortened-Aggrastat-Versus-Integrilin-in-Percutaneous-Coronary-Intervention/119198/2012-01-30weekly0.1http://trialreach.com/study/Airways-Dysfunction-Following-WTC-Dust-Exposure/82355/2012-01-30weekly0.1http://trialreach.com/study/Product-Surveillance-Registry/119216/2012-01-30weekly0.1http://trialreach.com/study/A-Randomized-Placebo-controlled-Double-blind-Phase-II-Study-Evaluating-if-Glucophage-Can-Avoid-Liver-Injury-Due-to-Chemo/119212/2012-01-30weekly0.1http://trialreach.com/study/Effects-of-Triptorelin-Pamoate-in-Children-With-Precocious-Puberty---Follow-up-Study/8764/2012-01-30weekly0.1http://trialreach.com/study/Descriptive-Study-in-Patients-Treated-With-Vimovo-Including-Registration-of-the-Physicians-Prescribing-Patterns/119227/2012-01-30weekly0.1http://trialreach.com/study/Hepatic-Arterial-Infusion-in-Treating-Patients-With-Locally-Advanced-Non-Metastatic-Cholangiocarcinoma/119186/2012-01-30weekly0.1http://trialreach.com/study/Predictive-Clinical-and-Biological-Parameters-in-Breast-Cancer/119202/2012-01-30weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Efficacy-and-Safety-of-GS-6624-Combined-With-Gemcitabine-for-Metastatic-Pancreatic-Adenocarcinom/119176/2012-01-30weekly0.1http://trialreach.com/study/ARQ-197-in-Combination-With-Chemotherapy-in-Patients-With-Metastatic-Colorectal-Cancer/104362/2012-01-30weekly0.1http://trialreach.com/study/Autologous-T-Cells-Low-Dose-Recombinant-Interferon-Gamma-Cyclophosphamide-and-Low-Dose-Aldesleukin-in-Treating-Patients-/119200/2012-01-30weekly0.1http://trialreach.com/study/A-Two-year-Study-of-Telbivudine-in-HBeAg-Negative-Hepatitis/119196/2012-01-30weekly0.1http://trialreach.com/study/Effect-of-High-intensity-Intermittent-Sprinting-on-Appetite-Control-on-Obese-Volunteers/86171/2012-01-30weekly0.1http://trialreach.com/study/MR-guided-Focused-Ultrasound-Treatment-of-Prostate-Cancer-Focal-Therapy-for-Locally-Non-Advanced-Disease/119206/2012-01-30weekly0.1http://trialreach.com/study/Arthroscopy-in-the-Treatment-of-Degenerative-Medial-Meniscus-Tear/49237/2012-01-30weekly0.1http://trialreach.com/study/Vaccine-Therapy-in-Curative-Resected-Prostate-Cancer-Patients/96739/2012-01-30weekly0.1http://trialreach.com/study/The-Muscle-Relaxation-study/119170/2012-01-30weekly0.1http://trialreach.com/study/Development-of-Knee-Osteoarthritis-After-Arthroscopic-Partial-Resection-of-Degenerative-Meniscus-Tear/54882/2012-01-30weekly0.1http://trialreach.com/study/Trial-of-Late-Surfactant-for-Prevention-of-Bronchopulmonary-Dysplasia/16119/2012-01-30weekly0.1http://trialreach.com/study/Medtronic-Registry-for-Epilepsy/119225/2012-01-30weekly0.1http://trialreach.com/study/Study-of-Sitagliptin-for-the-Treatment-of-Type-2-Diabetes-Mellitus-With-Inadequate-Glycemic-Control-on-Insulin-MK-0431-2/119184/2012-01-30weekly0.1http://trialreach.com/study/Intensified-Dosing-of-Cellcept-Mycophenolate-Mofetil-in-Kidney-Transplantation/37369/2012-01-30weekly0.1http://trialreach.com/study/Minocycline-in-Patients-With-Alzheimers-Disease/119194/2012-01-30weekly0.1http://trialreach.com/study/Comparing-the-Efficacy-and-Tolerability-of-Fulvestrant-500-mg-Versus-250-mg-in-Postmenopausal-Women-With-Advanced-Breast/109492/2012-01-30weekly0.1http://trialreach.com/study/Optic-Neuritis-Recovery-After-Oral-or-IV-Corticosteroids/119182/2012-01-30weekly0.1http://trialreach.com/study/A-Clinical-Investigation-of-New-Ostomy-Appliances/119228/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-Brentuximab-Vedotin-in-Patients-With-CD30-positive-Non-Hodgkin-Lymphoma/119168/2012-01-30weekly0.1http://trialreach.com/study/3-Grams-Daily-Valacyclovir-in-Chronic-Hepatitis-C-Infection-Phase-II/119180/2012-01-30weekly0.1http://trialreach.com/study/Acute-Effects-on-Glucose-and-Lipids-of-a-Low-fat-Diet-Low-carbohydrate-Diet-and-Mediterranean-Diet-in-Patients-With-Type/119229/2012-01-30weekly0.1http://trialreach.com/study/EXPOSURE-THERAPY-FOR-VETERANS-WITH-PTSD-AND-PANIC-ATTACKS/19394/2012-01-30weekly0.1http://trialreach.com/study/Effectiveness-of-Long-term-Oxygen-Therapy-in-Treating-People-With-Chronic-Obstructive-Pulmonary-Disease-The-Long-term-Ox/26162/2012-01-30weekly0.1http://trialreach.com/study/Patients-With-Metastatic-Colorectal-Cancer-Treated-With-Regorafenib-or-Placebo-After-Failure-of-Standard-Therapy/107941/2012-01-30weekly0.1http://trialreach.com/study/Advantage-of-Using-Intraoperative-Visual-Evoked-Potentials-to-Preserve-Visual-Function-During-Surgical-Procedures-Near-t/119204/2012-01-30weekly0.1http://trialreach.com/study/Randomized-Study-of-ON-01910Na-in-Refractory-Myelodysplastic-Syndrome-Patients-With-Excess-Blasts/105014/2012-01-30weekly0.1http://trialreach.com/study/Tolerability-and-Efficacy-of-Intravenous-Infusion-of-Autologous-MSCApceth-for-the-Treatment-of-Critical-Limb-Ischemia/110037/2012-01-30weekly0.1http://trialreach.com/study/Pilot-Study-Mindfulness-Based-Cognitive-Therapy-as-a-Tool-for-Prophylactic-Mood-Stabilizing-Therapy-in-Bipolar-Disorder/79336/2012-01-30weekly0.1http://trialreach.com/study/Conditioning-Regimen-and-the-Transplantation-of-Unrelated-Donor-Umbilical-Cord-Blood-in-Patients-With-Hematologic-Malign/19805/2012-01-30weekly0.1http://trialreach.com/study/Study-Looking-at-Longitudinal-Changes-in-Fatigue-and-Health-Status-in-Rheumatoid-Arthritis-RA-Patients-Treated-With-Subc/119231/2012-01-30weekly0.1http://trialreach.com/study/Intracutaneous-Sterile-Water-Injections/119161/2012-01-30weekly0.1http://trialreach.com/study/Pentoxifylline-Treatment-of-Acute-Pancreatitis/100846/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Tolerability-of-Sub-retinal-Transplantation-of-hESC-Derived-RPE-MA09-hRPE-Cells-in-Patients-With-Advanced-Dry/93082/2012-01-30weekly0.1http://trialreach.com/study/Atrial-and-Brain-Natriuretic-Peptide-Secretion-After-Percutaneous-Closure-of-the-Left-Atrial-Appendage/119163/2012-01-30weekly0.1http://trialreach.com/study/Procalcitonin-Monitoring-Sepsis-Study/119162/2012-01-30weekly0.1http://trialreach.com/study/Icotinib-Combined-With-WBRT-For-NSCLC-Patients-With-Brain-Metastases-and-EGFR-Mutation/119220/2012-01-30weekly0.1http://trialreach.com/study/StatinVitamin-D--Migraine-Study/110732/2012-01-30weekly0.1http://trialreach.com/study/Study-of-Lanreotide-in-Non-Metastatic-Castration-resistant-Prostate-Cancer-Patients/94858/2012-01-30weekly0.1http://trialreach.com/study/Combination-Immunotherapy-of-GMCD40L-Vaccine-With-CCL21-in-Lung-Cancer/119192/2012-01-30weekly0.1http://trialreach.com/study/The-Feeding-Dynamic-Intervention-Self-Regulation-of-Intake-in-Preschoolers/119164/2012-01-30weekly0.1http://trialreach.com/study/Tolerability-of-the-Combination-of-Lapatinib-and-Trastuzumab-in-Adults-Age-60-or-Older-With-HER2-Positive-Metastatic-Bre/99485/2012-01-30weekly0.1http://trialreach.com/study/Study-of-Acai-Juice-in-Asymptomatic-or-Minimally-Symptomatic-Prostate-Cancer-Patients-With-Rising-Prostate-Specific-Anti/119183/2012-01-30weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-AL-4943A-Ophthalmic-Solution-in-Patients-With-Allergic-Conjunctivitis-Using-the-Conjunctival-Alle/119232/2012-01-30weekly0.1http://trialreach.com/study/Administration-of-GRASPA-Suspension-of-Erythrocytes-Encapsulating-L-asparaginase-in-Elderly-Patients-With-First-Line-Acu/119205/2012-01-30weekly0.1http://trialreach.com/study/Safety-Tolerability-Pharmacokinetics-and-Pharmacodynamics-Study-of-YPEG-Filgrastim-in-Chemotherapy-Patients/89424/2012-01-30weekly0.1http://trialreach.com/study/A-Multi-centre-Study-of-MBVD-in-Elderly-andor-Cardiopathic-Patients-Affected-by-Hodgkins-Lymphoma-HL/119221/2012-01-30weekly0.1http://trialreach.com/study/A-Study-to-Determine-the-Optimal-Dose-of-SCH-900222-for-the-Treatment-of-Moderate-to-severe-Chronic-Plaque-Psoriasis-P05/98455/2012-01-30weekly0.1http://trialreach.com/study/Clinical-Trial-to-Investigate-the-Safety-Tolerability-and-Pharmacokinetics-of-DWP09031/119222/2012-01-30weekly0.1http://trialreach.com/study/Womens-Involvement-In-Decision-Making-At-Labor-And-Its-Effect-on-Their-Perceived-Labor-Process/119230/2012-01-30weekly0.1http://trialreach.com/study/Fatigue-and-Symptom-Burden-in-Febrile-Neutropenia/26956/2012-01-30weekly0.1http://trialreach.com/study/Multi-Tracer-PET-in-Early-Phase-Trials/110916/2012-01-30weekly0.1http://trialreach.com/study/Brentuximab-Vedotin-in-Patients-With-CD30-positive-Nonlymphomatous-Malignancies/119226/2012-01-30weekly0.1http://trialreach.com/study/A-Prospective-Non-interventional-Survey-to-Evaluate-Injection-Intervals-and-Treatment-Modalities-of-Botulinum-Toxin-A-Bo/99877/2012-01-30weekly0.1http://trialreach.com/study/Effects-of-rTMS-on-Cigarette-Smoking-and-Cognition-in-Schizophrenia/119167/2012-01-30weekly0.1http://trialreach.com/study/Utility-of-Interface-Pressure-Mapping/119233/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Pyridoxal-5--Phosphate-in-the-Treatment-of-Tardive-Dyskinesia/17544/2012-01-30weekly0.1http://trialreach.com/study/Sapacitabine-Cyclophosphamide-Rituximab-for-Relapsed-Chronic-Lymphocytic-Leukemia-Small-Lymphocytic-Lymphoma-CLLSLL-With/106731/2012-01-30weekly0.1http://trialreach.com/study/RituxanBendamustinePCI-32765-in-Relapsed-DLBCL-MCL-or-Indolent-Non-Hodgkins-Lymphoma/119179/2012-01-30weekly0.1http://trialreach.com/study/Phase-II-Clinical-Trial-of-Purified-Isoflavones-in-Prostate-Cancer-Comparing-Safety-Effectiveness/70599/2012-01-30weekly0.1http://trialreach.com/study/Quality-of-Life-Intermittent-Catheter-Study/119203/2012-01-30weekly0.1http://trialreach.com/study/Study-of-the-Effect-of-omega3-on-Biomarkers-of-Cardiac-Necrosis-CKMB-and-Troponin-I-and-Inflammation-Marker-CRP-After-El/119219/2012-01-30weekly0.1http://trialreach.com/study/VIGADEXA-Gel-Compared-to-VIGADEXA-Solution-Following-Cataract-Surgery/119165/2012-01-30weekly0.1http://trialreach.com/study/Cardiac-Resynchronization-and-Iodine-Meta-Iodobenzylguanidine-MIBG-Imaging/119234/2012-01-30weekly0.1http://trialreach.com/study/Reduction-of-Myocardial-Infarction-by-Preconditioning-in-Patients-With-Ruptured-Abdominal-Aortic-Aneurysm/64026/2012-01-30weekly0.1http://trialreach.com/study/Dysport-Adult-Lower-Limb-Spasticity-Study/91162/2012-01-30weekly0.1http://trialreach.com/study/Clinical-Study-to-Evaluate-Safety-and-Maximum-Tolerated-Dose-of-BAY1000394-Given-in-a-4-Week-on--2-Week-Off-Schedule-in-/108080/2012-01-30weekly0.1http://trialreach.com/study/Evaluating-the-Haemostatic-Effect-of-NNC-0129-0000-1003-During-Surgical-Procedures-in-Subjects-With-Haemophilia-A/119178/2012-01-30weekly0.1http://trialreach.com/study/Safety-and-Tolerability-of-Single-Doses-Oral-CNDO-201-Trichuris-Suis-Ova-in-Patients-With-Crohns-Disease/119207/2012-01-30weekly0.1http://trialreach.com/study/Randomized-Double-Blind-Controlled-Trial-Comparing-a-Blind-Sciatic-Nerve-Block-in-the-Popliteal-Fossa-to-Intravenous-Mor/119235/2012-01-30weekly0.1http://trialreach.com/study/Standard-Dose-Versus-High-Dose-Inactivated-Flu-Vaccine-in-Pediatric-Solid-Organ-Transplant-Patients/119208/2012-01-30weekly0.1http://trialreach.com/study/Safety-Study-of-Continuous-Positive-Airway-Pressure-Via-a-Nasal-Mask/119218/2012-01-30weekly0.1http://trialreach.com/study/Everolimus-With-Multiagent-Re-Induction-Chemotherapy-in-Pediatric-Patients-With-ALL/119187/2012-01-30weekly0.1http://trialreach.com/study/Effects-of-Aerobic-Exercise-Within-a-Behavioral-Treatment-Program-for-Chronic-Headaches/119197/2012-01-30weekly0.1http://trialreach.com/study/Monitoring-and-Modifying-Atherosclerosis-in-Psoriasis-Patients-Study/119177/2012-01-30weekly0.1http://trialreach.com/study/Gemcitabine-and-Oxaliplatin-in-the-Management-of-Metastatic-Pancreatic-Cancers-With-Low-Expression-of-ERCC1/119217/2012-01-30weekly0.1http://trialreach.com/study/A-Study-of-Canagliflozin-and-Metformin-Immediate-Release-150-mg500-mg-FDC-Tablets-in-Healthy-Volunteers/119166/2012-01-30weekly0.1http://trialreach.com/study/PA21-Phase-II-Clinical-Study-in-Hemodialysis-Patients-With-Hyperphosphatemia/119188/2012-01-30weekly0.1http://trialreach.com/study/Observational-Post-marketing-Study-on-the-Safety-and-Efficacy-of-Dotarem-SECURE-Study/119172/2012-01-30weekly0.1http://trialreach.com/study/Phase-II-Trial-Evaluating-Axitinib-In-Patients-With-Unresectable-Recurrent-Or-Metastatic-Head-And-Neck-Cancer/119173/2012-01-30weekly0.1http://trialreach.com/study/Study-of-JI-101-in-Patients-With-Advanced-Low-Grade-Endocrine-Tumors-Ovarian-Cancers-or-K-RAS-Mutant-Colon-Cancers/100393/2012-01-30weekly0.1http://trialreach.com/study/Gene-Transfer-for-Recessive-Dystrophic-Epidermolysis-Bullosa/112080/2012-01-29weekly0.1http://trialreach.com/study/Patient-Satisfaction-With-Novel-Double-Pants-Compared-to-Conventional-Single-Pants-for-Outpatient-Colonoscopy/119150/2012-01-29weekly0.1http://trialreach.com/study/Healthy-Infant-Development-Project/62566/2012-01-29weekly0.1http://trialreach.com/study/68Ga-DOTATATE-PETCT-in-Oncogenic-Osteomalacia/119151/2012-01-29weekly0.1http://trialreach.com/study/The-Impact-of-Early-Embryos-Incubation-on-Pregnancy-Rate-in-IVF/86518/2012-01-29weekly0.1http://trialreach.com/study/Effects-of-Obesity-Surgery-on-Renal-Function/119152/2012-01-29weekly0.1http://trialreach.com/study/Clinical-Trial-to-Assess-the-Efficacy-and-Safety-of-INNOCELL-Immuncell-LC-With-Temozolomide-in-Newly-Diagnosed-Glioblast/2600/2012-01-29weekly0.1http://trialreach.com/study/Hypo-fractionated-Proton-Radiation-Therapy-With-or-Without-Androgen-Suppression-for-Intermediate-Risk-Adenocarcinoma-of-/119153/2012-01-29weekly0.1http://trialreach.com/study/Effects-of-Flutamide-on-Insulin-and-Glucose-Metabolism-in-Women-With-Polycystic-Ovary-Syndrome/55814/2012-01-29weekly0.1http://trialreach.com/study/Study-of-Biostate-in-Children-With-Von-Willebrand-Disease/96707/2012-01-29weekly0.1http://trialreach.com/study/Responsiveness-of-Exercise-Tests-in-Pulmonary-Arterial-Hypertension/99099/2012-01-29weekly0.1http://trialreach.com/study/Radiofrequency-Ablation-for-the-Treatment-of-Gastric-Dysplasia/119154/2012-01-29weekly0.1http://trialreach.com/study/Effects-of-Different-Interventions-on-Glycemic-Control-and--cell-Function-in-Newly-Diagnosed-Type-2-Diabetic-Patients/108544/2012-01-29weekly0.1http://trialreach.com/study/A-Study-in-Healthy-Volunteers-to-Evaluate-the-Safety-Tolerability-and-Pharmacokinetics-Profiles-of-Single-and-Multiple-A/119155/2012-01-29weekly0.1http://trialreach.com/study/Targeted-Radiotherapy-in-HSCT-for-Poor-Risk-Haematological-Malignancy/119156/2012-01-29weekly0.1http://trialreach.com/study/Prevalence-of-Pneumocystis-Jirovecii-and-of-Cytomegalovirus-in-Bronchial-Wash-Fluid-of-Patients-Undergoing-Bronchoscopy/96381/2012-01-29weekly0.1http://trialreach.com/study/Chinese-Cancer-Prevention-StudyCHICAPS/119157/2012-01-29weekly0.1http://trialreach.com/study/Genetic-Testing-in-Primary-Congenital-Glaucoma-Patients/98020/2012-01-29weekly0.1http://trialreach.com/study/Face-Anthropometric-Pattern-Recognition-Technology-for-Computer-Aided-Diagnosis-of-Human-Genetic-Disorders/15278/2012-01-29weekly0.1http://trialreach.com/study/Observational-Study-of-Prophylaxis-and-Treatment-of-Acute-Perioperative-Bleeding-With-Beriplex-PN-Probe-Study/23361/2012-01-29weekly0.1http://trialreach.com/study/Study-of-Biostate-in-Children-With-Hemophilia-A/94781/2012-01-29weekly0.1http://trialreach.com/study/Glyburide-and-Metformin-for-Gestational-Diabetes-Mellitus-GDM/100295/2012-01-29weekly0.1http://trialreach.com/study/Endoscopy-and-Endomicroscopy-for-Assessment-of-Mucosal-Healing-in-Inflammatory-Bowel-Disease-IBD/119158/2012-01-29weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Gabapentin-in-Treating-Overactive-Bladder/119160/2012-01-29weekly0.1http://trialreach.com/study/Resolution-of-Comorbidities--Safety-and-Efficacy-of-Greater-Curvature-Plication-in-Obese-Patients/119159/2012-01-29weekly0.1http://trialreach.com/study/Pemetrexed-Disodium-or-Observation-in-Treating-Patients-With-Malignant-Pleural-Mesothelioma-Without-Progressive-Disease-/99020/2012-01-28weekly0.1http://trialreach.com/study/BELotaxelDocetaxel-and-bellOXaOxaliplatin-in-Advanced-NSCLC/112619/2012-01-28weekly0.1http://trialreach.com/study/Study-of-Disease-Severity-in-Adults-With-Neurofibromatosis-Type-1-NF1/43857/2012-01-28weekly0.1http://trialreach.com/study/PET-Scan-Imaging-in-Assessing-Response-in-Patients-With-Esophageal-Cancer-Receiving-Combination-Chemotherapy/101979/2012-01-28weekly0.1http://trialreach.com/study/A-Study-of-the-Kinetics-of-Lymphoid-Cells-in-Patients-With-Monoclonal-B-cell-Lymphocytosis-MBL-Chronic-Lymphocytic-Leuke/109100/2012-01-28weekly0.1http://trialreach.com/study/Chemotherapy-With-or-Without-Bevacizumab-in-Treating-Women-With-Stage-I-Stage-II-or-Stage-IIIA-Breast-Cancer-That-Can-Be/40022/2012-01-28weekly0.1http://trialreach.com/study/Gene-Expression-in-Samples-From-Patients-With-T-Cell-Acute-Lymphoblastic-Leukemia/119143/2012-01-28weekly0.1http://trialreach.com/study/ABT-888-Plus-Metronomic-Cyclophosphamide-to-Treat-Cancer/119146/2012-01-28weekly0.1http://trialreach.com/study/Role-of-Genetic-Factors-in-the-Development-of-Lung-Disease/69163/2012-01-28weekly0.1http://trialreach.com/study/DTI-Study-of-the-Influence-of-Physiotherapy-on-Distribution-of-BoNT-in-Spastic-Muscle/119147/2012-01-28weekly0.1http://trialreach.com/study/A-Prospective-Observational-Study-Evaluating-c-MET-Expression-and-EGFR-Gene-Mutation-Correlation-With-Erlotinib-Response/119144/2012-01-28weekly0.1http://trialreach.com/study/Natural-History-of-Bronchiectasis/61946/2012-01-28weekly0.1http://trialreach.com/study/Seneca-Valley-Virus-001-After-Chemotherapy-in-Treating-Patients-With-Extensive-Stage-Small-Cell-Lung-Cancer/45693/2012-01-28weekly0.1http://trialreach.com/study/L-carnitine-to-Treat-Fatigue-Associated-With-Crohns-Disease/119148/2012-01-28weekly0.1http://trialreach.com/study/Gene-Expression-in-Predicting-Outcome-in-Samples-From-Patients-With-High-Risk-Neuroblastoma/119145/2012-01-28weekly0.1http://trialreach.com/study/Probiotics-Against-Pathogenic-Bacteria-in-Connection-With-Anaesthesia/119149/2012-01-28weekly0.1http://trialreach.com/study/Gemcitabine-Carboplatin-and-Lenalidomide-for-Treatment-of-AdvancedMetastatic-Urothelial-Cancer-and-Other-Solid-Tumors/87757/2012-01-28weekly0.1http://trialreach.com/study/Fluorodeoxyglucose-Positron-Emission-Tomography-FDG-PET-to-Evaluate-Autoimmune-Lymphoproliferative-Syndrome-ALPS-and-ALP/38080/2012-01-28weekly0.1http://trialreach.com/study/Green-Tea-and-Reduction-of-Breast-Cancer-Risk/39553/2012-01-27weekly0.1http://trialreach.com/study/A-Trial-of-Boost-Vaccinations-of-Pancreatic-Tumor-Cell-Vaccine/85100/2012-01-27weekly0.1http://trialreach.com/study/18F-Fluoro-2-Deoxy-D-Glucose-and--18F-Dihydro-Testosterone-Pet-Imaging-in-Patients-With-Progressive-Prostate-Cancer/34524/2012-01-27weekly0.1http://trialreach.com/study/MOTION-Safinamide-in-Early-Idiopathic-Parkinsons-Disease-IPD-as-add-on-to-Dopamine-Agonist-Extension-of-Trial-27918/73290/2012-01-27weekly0.1http://trialreach.com/study/Pharmacogenetics-of-Nicotine-Addiction-Treatment/101925/2012-01-27weekly0.1http://trialreach.com/study/MLN8237-in-Adults-With-Nonhematological-Malignancies-Followed-by-MLN8237-in-Lung-Breast-Head-and-Neck-or-Gastroesophagea/26560/2012-01-27weekly0.1http://trialreach.com/study/Effect-of-NovoTTF-100A-Together-With-Temozolomide-in-Newly-Diagnosed-Glioblastoma-Multiforme-GBM/23068/2012-01-27weekly0.1http://trialreach.com/study/Modification-of-Cerebral-Activity-of-Obsessive-Compulsive-Disorder-OCD-Patients-During-Cognitive-and-Behavioral-Therapy/98027/2012-01-27weekly0.1http://trialreach.com/study/Cluster-Randomized-Trial-on-Long-Acting-Reversible-Contraception-LARC-Education-and-Training/104472/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-JNS020QD-in-Patients-With-Chronic-Pain/113406/2012-01-27weekly0.1http://trialreach.com/study/Pilot-Study-Safety-of-a-Customized-MRI-System-for-Neonatal-Imaging/119058/2012-01-27weekly0.1http://trialreach.com/study/Study-Evaluating-OsseoSpeed-Implants-in-the-Upper-Jaw-in-Women-With-Osteoporosis/6528/2012-01-27weekly0.1http://trialreach.com/study/The-Effect-of-Aliskiren-on-Endothelial-Function-in-Pre-Diabetes-and-Diabetes/95333/2012-01-27weekly0.1http://trialreach.com/study/Permeability-Factor-in-Focal-Segmental-Glomerulosclerosis/20433/2012-01-27weekly0.1http://trialreach.com/study/Acceleration-and-Relapse-Prevention-With-Triiodothyronine-T3-as-an-Adjunct-to-Electroconvulsive-Therapy-ECT/90133/2012-01-27weekly0.1http://trialreach.com/study/Hancock-II-Ultra-Porcine-Bioprosthesis-Hemodynamic-Study/103727/2012-01-27weekly0.1http://trialreach.com/study/Administration-of-Tadalafil-in-Conjunction-With-Lenalidomide-and-Dexamethasone-in-Patients-With-Multiple-Myeloma/107163/2012-01-27weekly0.1http://trialreach.com/study/Phase-3-Study-of-Obeticholic-Acid-in-Patients-With-Primary-Biliary-Cirrhosis/112989/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-a-Human-Anti-Intercellular-Adhesion-Molecule-1-Monoclonal-Antibody-in-Patients-With-Multiple-Myeloma/70805/2012-01-27weekly0.1http://trialreach.com/study/Implementing-Evidence-Based-Mental-Health-Practices-in-Primary-Care/65302/2012-01-27weekly0.1http://trialreach.com/study/Natural-History-Genetic-Bases-and-Phenotype-genotype-Correlations-in-Autosomal-Dominant-Spinocerebellar-Degenerations/22709/2012-01-27weekly0.1http://trialreach.com/study/Detection-of-Thyrotrophin-Receptor-in-Human-Myometrium/86942/2012-01-27weekly0.1http://trialreach.com/study/Optimized-Donor-Selection-Nonmyeloablative-BMT-for-B-cell-Lymphomas-With-Post-transplantation-Cy-and-Rituximab/74715/2012-01-27weekly0.1http://trialreach.com/study/Changes-in-Brown-Adipose-Tissue-Activity-In-Men-Receiving-Androgen-Deprivation-Therapy-for-Prostate-Cancer/97621/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-the-Association-Between-Autism-and-Immune-Changes-in-the-Brain/110251/2012-01-27weekly0.1http://trialreach.com/study/MOTION-Safinamide-in-Early-IPD-as-add-on-to-Dopamine-Agonist/6809/2012-01-27weekly0.1http://trialreach.com/study/Effects-of-Glutamine-in-Ischemic-Heart-Disease-Patients-Following-Cardiopulmonary-Bypass/119057/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-Individualized-Stereotactic-Body-Radiation-Therapy-SBRT-for-Intrahepatic-Cancer/119082/2012-01-27weekly0.1http://trialreach.com/study/Acupuncture-Like-Transcutaneous-Electrical-Nerve-Stimulation-ALTENS-or-Pilocarpine-in-Treating-Early-Dry-Mouth-in-Patien/14640/2012-01-27weekly0.1http://trialreach.com/study/Dexmedetomidine-Versus-Fentanyl-Following-Pressure-Equalization-Tube-Placement/102517/2012-01-27weekly0.1http://trialreach.com/study/High-Dose-Cholecalciferol-in-Premenopausal-Women-at-High-Risk-for-Breast-Cancer/96117/2012-01-27weekly0.1http://trialreach.com/study/Entinostat-and-Clofarabine-in-Treating-Patients-With-Newly-Diagnosed-Relapsed-or-Refractory-Poor-Risk-Acute-Lymphoblasti/97956/2012-01-27weekly0.1http://trialreach.com/study/Efficacy-and-Safety-Study-of-iSONEP-With-and-Without-LucentisAvastin-to-Treat-Age-related-Macular-Degeneration-AMD/106216/2012-01-27weekly0.1http://trialreach.com/study/CetuGEX-Dose-Escalation-Study/108431/2012-01-27weekly0.1http://trialreach.com/study/NucleiparkHigh-Field-MR-Imaging-7T-and-3T-of-the-Brainstem-the-Deep-Nuclei-and-Their-Connections-in-the-Parkinsonian-Syn/95663/2012-01-27weekly0.1http://trialreach.com/study/Safety-Tolerability-and-Effects-of-L-Arginine-in-Boys-With-Dystrophinopathy-on-Corticosteroids/101808/2012-01-27weekly0.1http://trialreach.com/study/Protein-Blends-Soy-Whey-and-Casein-for-Muscle-Synthesis/111832/2012-01-27weekly0.1http://trialreach.com/study/CNAP-Monitor-Study/91056/2012-01-27weekly0.1http://trialreach.com/study/Clinical-Molecular-and-by-Neuroimaging-of-LRRK2-Mutations/91712/2012-01-27weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Effect-of-Ranolazine-and-Dronedarone-When-Given-Alone-and-in-Combination-in-Patients-With-Paroxy/119123/2012-01-27weekly0.1http://trialreach.com/study/Study-of-Gardasil-in-Mid-Adult-Males-MAM/119059/2012-01-27weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-Sildenafil-for-the-Treatment-of-Lymphatic-Malformations/92582/2012-01-27weekly0.1http://trialreach.com/study/Study-of-a-Novel-Indibulin-Dosing-Schedule-for-the-Treatment-of-Metastatic-Breast-Cancer/101938/2012-01-27weekly0.1http://trialreach.com/study/31P-MRS-and-Huntington-Disease/96792/2012-01-27weekly0.1http://trialreach.com/study/Neurobiology-of-Psychogenic-Movement-Disorder-and-Non-Epileptic-Seizures/54579/2012-01-27weekly0.1http://trialreach.com/study/Vorinostat-MK0683-SAHA--Revlimid--Dexamethasone-in-Multiple-Myeloma-MK-0683-074-AM3/55071/2012-01-27weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Exenatide-as-Monotherapy-and-Adjunctive-Therapy-to-Oral-Antidiabetic-Agents-in-Adolescents-With-T/2815/2012-01-27weekly0.1http://trialreach.com/study/Identification-Of-Blood-Markers-For-Asymptomatic-Ventricular-Dysfunction/74299/2012-01-27weekly0.1http://trialreach.com/study/Laboratory-Treated-Autologous-Lymphocytes-Aldesleukin-and-GM-CSF-in-Treating-Patients-With-Recurrent-Refractory-or-Metas/80611/2012-01-27weekly0.1http://trialreach.com/study/Study-to-Evaluate-the-Effect-of-Sulforaphane-in-Broccoli-Sprout-Extract-on-Breast-Tissue/9056/2012-01-27weekly0.1http://trialreach.com/study/KatGuide-Method-Versus-Conventional-Method-at-Insertion-of-Chest-Tube/119060/2012-01-27weekly0.1http://trialreach.com/study/Intra-arterial-Y-90-TheraSpheres-for-Hepatic-Metastases-From-Solid-Tumors/103639/2012-01-27weekly0.1http://trialreach.com/study/A-Study-in-Healthy-Participants-Investigating-the-Safety-Tolerability-and-Plasma-Pharmacokinetics-PK-of-Single-Oral-Dose/119061/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-IMC-3G3-in-Previously-Treated-Patients-With-Unresectable-andor-Metastatic-Gastrointestinal-Stromal-Tumors/106701/2012-01-27weekly0.1http://trialreach.com/study/Type-2-Diabetes-and-Obesity-in-Mexican-Pimas-Gene-Environment-Interaction/94850/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-the-Safety-and-Pharmacokinetics-of-JNJ-38518168-in-Japanese-and-Caucasian-Male-Participants-and-the-Effect-of/119106/2012-01-27weekly0.1http://trialreach.com/study/Knee-Arthroplasty-Performed-With-Conventional-and-Customized-Instrumentation/89400/2012-01-27weekly0.1http://trialreach.com/study/Determination-of-the-Pathophysicologic-Collagen-Changes-in-the-Diabetic-Achilles-Tendon/89976/2012-01-27weekly0.1http://trialreach.com/study/Effects-of-Pre--Pro---Anti-biotics-on-Gut-Microbiota/91825/2012-01-27weekly0.1http://trialreach.com/study/Early-Versus-Late-Concurrent-Chemoradiation-for-Limited-Stage-Small-cell-Lung-Cancer/87540/2012-01-27weekly0.1http://trialreach.com/study/Long-term-Outcome-and-Lung-Capacity-in-Survivors-of-ARDS-Due-to-Influenza-A-H1N1-v2009-The-RESPIFLU-Study/86415/2012-01-27weekly0.1http://trialreach.com/study/Comparison-of-Bone-Mineral-Loss-in-Prostate-Cancer-Patients-Who-is-Receiving-GnRH-Agonist-and--Plus-Anti-androgen-Agent/99999/2012-01-27weekly0.1http://trialreach.com/study/The-Effect-of-NK1R-Antagonism-on-Alcohol-Craving-and-PTSD-Symptoms-in-Alcohol-Dependent-Patients-With-PTSD/74155/2012-01-27weekly0.1http://trialreach.com/study/Study-of-GO-203-2C-Given-Intravenously-in-Patients-With-Advanced-Solid-Tumors/97177/2012-01-27weekly0.1http://trialreach.com/study/Abnormal-Structure-and-Bone-Density-in-Diabetes/110221/2012-01-27weekly0.1http://trialreach.com/study/A-Feasibility-Study-Using-Four-Dimensional-CT-Imaging-for-Primary-Lung-Cancer/119078/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-Erythromycin-and-Rivaroxaban-in-Study-Participants-With-Normal-and-Reduced-Kidney-Function/110650/2012-01-27weekly0.1http://trialreach.com/study/Contrast-Enhanced-CT-Scan-and-Contrast-Enhanced-MRI-in-Diagnosing-and-Staging-Liver-Cancer-in-Patients-With-Chronic-Live/100609/2012-01-27weekly0.1http://trialreach.com/study/Evaluation-of-Limb-Girdle-Muscular-Dystrophy/54181/2012-01-27weekly0.1http://trialreach.com/study/Interaction-Between-a-Calcimimetic-Agent-and-the-Renin-Angiotensine-Aldosterone-System/119139/2012-01-27weekly0.1http://trialreach.com/study/Measuring-Real-Time-Decision-Making-About-Ultraviolet-Radiation-UVR-Protection/7826/2012-01-27weekly0.1http://trialreach.com/study/Controlled-Trial-of-Deep-Brain-Stimulation-in-Early-Patients-With-Parkinsons-Disease/37583/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-Efficacy-and-Safety-of-Ustekinumab-in-Patients-With-Primary-Biliary-Cirrhosis-PBC-Who-Had-an-Inadequate-Respo/112078/2012-01-27weekly0.1http://trialreach.com/study/Effect-of-6-week-Strawberry-Supplementation-on-Insulin-Action-STR2/119062/2012-01-27weekly0.1http://trialreach.com/study/Serum-Markers-in-Gluten-Challenge/39453/2012-01-27weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Safety-and-Efficacy-of-Ustekinumab-Maintenance-Therapy-in-Patients-With-Moderately-to-Severely-A/103581/2012-01-27weekly0.1http://trialreach.com/study/Trastuzumab-Cyclophosphamide-and-Vaccine-Therapy-in-Treating-Patients-With-High-Risk-or-Metastatic-Breast-Cancer/40395/2012-01-27weekly0.1http://trialreach.com/study/Medicinal-Nicotine-for-Preventing-Stress-Induced-Craving-and-Withdrawal-Symptoms/119079/2012-01-27weekly0.1http://trialreach.com/study/Celecoxib-in-Treating-Patients-With-Cervical-Intraepithelial-Neoplasia/42526/2012-01-27weekly0.1http://trialreach.com/study/Open-Label-Study-of-Subcutaneous-Homoharringtonine-Omacetaxine-Mepesuccinate-in-Patients-With-Advanced-CML/70011/2012-01-27weekly0.1http://trialreach.com/study/Sorafenib-and-Dacarbazine-in-Soft-Tissue-Sarcoma/6692/2012-01-27weekly0.1http://trialreach.com/study/Advancing-Adolescent-Screening-and-Brief-Intervention-Protocols-in-Primary-Care-Settings/119134/2012-01-27weekly0.1http://trialreach.com/study/Response-of-Alkylresorcinols-to-Different-Cereals/89203/2012-01-27weekly0.1http://trialreach.com/study/Prevention-of-Acute-Kidney-Injury-by-Erythropoietin-in-Thoracic-Aorta-Surgery-With-Hypothermic-Cardiac-Arrest/104496/2012-01-27weekly0.1http://trialreach.com/study/PankoMab-GEX-Dose-Escalation-Study/97844/2012-01-27weekly0.1http://trialreach.com/study/Structural-and-Functional-Connectivity-in-Partial-Epilepsies-Studied-With-MRI-and-MEG/103868/2012-01-27weekly0.1http://trialreach.com/study/Study-of-GORE-BIO-A-Fistula-Plug-for-Use-in-Anal-Fistula-Repair/101639/2012-01-27weekly0.1http://trialreach.com/study/Screening-Protocol-for-the-Evaluation-of-Potential-Research-Subjects/35806/2012-01-27weekly0.1http://trialreach.com/study/Trial-of-High-Dose-Lenalidomide-in-Patients-With-Myelodysplastic-Syndrome-MDS-and-Acute-Myeloid-Leukemia-AML-With-Trilin/939/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-Varespladib-Infusion-in-Subjects-With-Sickle-Cell-Disease/119063/2012-01-27weekly0.1http://trialreach.com/study/Contractubex-Treatment-in-Scars-After-Abdominal-Caesarean-Section/106871/2012-01-27weekly0.1http://trialreach.com/study/Persistent-Pain-After-Breast-Cancer-Treatment-PPBCT---Risk-Factors-and-Pathophysiological-Mechanisms/119120/2012-01-27weekly0.1http://trialreach.com/study/Cocaine-Use-Reduction-With-Buprenorphine/106418/2012-01-27weekly0.1http://trialreach.com/study/Controlled-Comparison-of-Two-Moxifloxacin-Containing-Treatment-Shortening-Regimens-in-Pulmonary-Tuberculosis/51505/2012-01-27weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-YKP3089-in-Subjects-With-Treatment-Resistant-Partial-Onset-Seizures/103573/2012-01-27weekly0.1http://trialreach.com/study/Study-of-Paliperidone-Palmitate-3-Month-and-1-Month-Formulations-for-the-Treatment-of-Patients-With-Schizophrenia/119083/2012-01-27weekly0.1http://trialreach.com/study/Pilot-Study-Using-Molecular-Profiling-to-Find-Potential-Targets-and-Select-Treatments-for-Patients-With-Metastatic-Breas/103944/2012-01-27weekly0.1http://trialreach.com/study/Heparin-Solution-and-INTEMHEPTEM-Analysis/119065/2012-01-27weekly0.1http://trialreach.com/study/Peripheral-Muscle-Microcirculation-and-Exercise-induced-Blood-Flow-Distribution-in-Pulmonary-Arterial-Hypertension/119121/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-the-Safety-Tolerability-Pharmacokinetics-What-the-Body-Does-to-the-Drug-and-Pharmacodynamics-What-the-Drug-Do/119064/2012-01-27weekly0.1http://trialreach.com/study/Assessment-of-an-Accelerometric-Measurement-Device-for-Gait-Analysis/119125/2012-01-27weekly0.1http://trialreach.com/study/Diffuse-Optical-Spectroscopy-Imaging-in-Monitoring-and-Predicting-Response-in-Patients-With-Locally-Advanced-Breast-Canc/94777/2012-01-27weekly0.1http://trialreach.com/study/TMC435HPC2002---Phase-II-Trial-of-TMC435-in-Combination-With-PSI-7977-in-Prior-G1-Null-Responders-to-Peg-IFNRBV-Hepatiti/119088/2012-01-27weekly0.1http://trialreach.com/study/Entinostat-And-Imatinib-Mesylate-In-Treating-Patients-With-Relapsed-or-Refractory-Philadelphia-Chromosome-Positive-Acute/105335/2012-01-27weekly0.1http://trialreach.com/study/Effect-of-Docosahexaenoic-Acid-DHA-Enriched-Human-Milk-in-Premature-Newborns/85612/2012-01-27weekly0.1http://trialreach.com/study/PharmacokineticsPharmacodynamics-of-NOX-H94-in-the-Human-Endotoxemia-Model/119124/2012-01-27weekly0.1http://trialreach.com/study/Effects-of-Whole-Sprouts-on-Upper-Airway-Allergic-Inflammation/119140/2012-01-27weekly0.1http://trialreach.com/study/BOTOX-in-Men-With-Prostate-Cancer-With-Lower-Urinary-Tract-SymptomsLUTSBenign-Prostatic-Hyperplasia-BPH/119133/2012-01-27weekly0.1http://trialreach.com/study/Effect-of-Increased-Free-Fatty-Acids-on-Leptin-Function/119085/2012-01-27weekly0.1http://trialreach.com/study/Influence-of-Breakfast-Consumption-on-Chlorogenic-Acid-Metabolism-in-Humans/119101/2012-01-27weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-YHD001-in-Asthma/119084/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-the-Histone-Deacetylase-Inhibitor-HDACi-JNJ-26481585-in-Patients-With-Previously-Treated-Stage-Ib-IVa-Cutaneo/119116/2012-01-27weekly0.1http://trialreach.com/study/PD-0332991-5-FU-and-Oxaliplatin-for-Advanced-Colorectal-Cancer/119109/2012-01-27weekly0.1http://trialreach.com/study/Comparison-of-Metoclopramide-and-Ibuprofen-for-the-Treatment-of-Acute-Mountain-Sickness/119067/2012-01-27weekly0.1http://trialreach.com/study/In-Vivo-Leptin-Signaling-in-Humans-After-Acute-Leptin-Administration/106328/2012-01-27weekly0.1http://trialreach.com/study/Effects-of-Atomoxetine-in-Mild-Cognitive-Impairment/119066/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-Active-Immunotherapy-With-GRNVAC1-in-Patients-With-Acute-Myelogenous-Leukemia-AML/15308/2012-01-27weekly0.1http://trialreach.com/study/Treatment-of-Patients-With-Recently-Exacerbated-Schizophrenia-With-Paliperidone-Palmitate/119114/2012-01-27weekly0.1http://trialreach.com/study/Safety-Study-of-the-Drug-MM-151-in-Patients-With-Advanced-Solid-Tumors-Resisting-Ordinary-Treatment/119081/2012-01-27weekly0.1http://trialreach.com/study/A-Clinical-Trials-of-Quick-Acting-Heart-Reliever-for-Moderate-Coronary-Stenosis/119098/2012-01-27weekly0.1http://trialreach.com/study/A-Clinical-Trial-Comparing-the-Efficacy-of-DarunavirRitonavir-Monotherapy-Versus-a-Triple-Combination-Therapy-Containing/119100/2012-01-27weekly0.1http://trialreach.com/study/Whole-Body-Vibration-Training-Among-Older-People-Using-Sheltered-Housing/119068/2012-01-27weekly0.1http://trialreach.com/study/Attention-Training/119086/2012-01-27weekly0.1http://trialreach.com/study/Safe-and-Efficacious-Artemisinin-based-Combination-Treatments-for-African-Pregnant-Women-With-Malaria/19065/2012-01-27weekly0.1http://trialreach.com/study/Food-Effect-on-Pharmacokinetics-of-YH4808-in-Healthy-Male-Subjects/119096/2012-01-27weekly0.1http://trialreach.com/study/Curbing-Tobacco-Use-in-Suburban-and-Rural-Schools/2380/2012-01-27weekly0.1http://trialreach.com/study/A-Study-to-Evaluate-the-Safety-and-Antitumor-Activity-in-Subjects-With-Advanced-Solid-Tumor/97189/2012-01-27weekly0.1http://trialreach.com/study/Imaging-of-Brain-Receptors-Using-11CmGlu1/119113/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-DEDN6526A-in-Patients-With-Metastatic-or-Unresectable-Melanoma/119141/2012-01-27weekly0.1http://trialreach.com/study/A-Dose-Escalation-Study-of-the-Histone-Deacetylase-Inhibitor-HDACi-JNJ-26481585-in-Combination-With-VELCADE-Bortezomib-a/119102/2012-01-27weekly0.1http://trialreach.com/study/A-Trial-Exploring-the-Efficacy-of-EMD-1201081-in-Combination-With-Cetuximab-in-Second-Line-Cetuximab-Nave-Subjects-With-/16564/2012-01-27weekly0.1http://trialreach.com/study/Comparison-of-Outcomes-Between-Early-Physical-Therapy-Intervention-and-Usual-Care-Following-Anterior-Cervical-Fusion-Sur/119130/2012-01-27weekly0.1http://trialreach.com/study/Methylphenidate-Hydrochloride-or-Modafinil-in-Treating-Young-Patients-With-Excessive-Daytime-Sleepiness-After-Cancer-The/92862/2012-01-27weekly0.1http://trialreach.com/study/Ibutilide-Administration-During-Pulmonary-Vein-Ablation/714/2012-01-27weekly0.1http://trialreach.com/study/Antiretrovirals-and-Rate-of-Progression-in-Carotid-Artery-Intima-medial-Thickness-in-HIV/26900/2012-01-27weekly0.1http://trialreach.com/study/Julina-Post-marketing-Surveillance-for-Climacteric-Symptoms-in-Japan/96892/2012-01-27weekly0.1http://trialreach.com/study/A-Model-for-Genetic-Susceptibility-Melanoma/72446/2012-01-27weekly0.1http://trialreach.com/study/Trial-of-Activated-Marrow-Infiltrating-Lymphocytes-Alone-or-in-Conjunction-With-an-Allogeneic-Granulocyte-Macrophage-Col/26914/2012-01-27weekly0.1http://trialreach.com/study/Predictive-Factors-of-a-Successful-Implant-of-the-CapsureFix-MRI-Model-5086/119069/2012-01-27weekly0.1http://trialreach.com/study/Phase-2A-Study-of-NPC-1C-Chimeric-Monoclonal-Antibody-to-Treat-Pancreatic-and-Colorectal-Cancer/71668/2012-01-27weekly0.1http://trialreach.com/study/RISCA--Prospective-Study-of-Individuals-at-Risk-for-SCA1-SCA2-SCA3-SCA6-SCA7/74051/2012-01-27weekly0.1http://trialreach.com/study/Ultrasound-guided-Genitofemoral-Iliohypogastric-and-Ilioinguinal-Nerve-Block-for-Inguinal-Hernia-Surgery/119142/2012-01-27weekly0.1http://trialreach.com/study/A-Two-Arm-Trial-of-Axitinib-and-CarboplatinPaclitaxel-in-Melanoma-CC-10852/91505/2012-01-27weekly0.1http://trialreach.com/study/Interventions-to-Prevent-Adolescents-With-Type-1-Diabetes-From-Long-term-Complications/119108/2012-01-27weekly0.1http://trialreach.com/study/A-Single-Dose-Pilot-Study-of-Radiolabeled-Amatuximab-MORAb-009-in-Mesothelin-Over-Expressing-Cancers/119099/2012-01-27weekly0.1http://trialreach.com/study/Immunization-With-a-Pentavalent-Vaccine-Composed-of-KLH-conjugates-of-GD2L-GD3L-Globo-H-Fucosyl-GM1-and-N-Propionylated-/98036/2012-01-27weekly0.1http://trialreach.com/study/Quit-Smoking-With-Nicotine-Patch-and-ExerciseHealth-Education-Females-Only/119132/2012-01-27weekly0.1http://trialreach.com/study/Evaluating-the-Effectiveness-of-Intravenous-Immunoglobulin-Therapy-in-Autoimmune-Autonomic-Ganglionopathy/119122/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-Abiraterone-Acetate-Plus-Prednisone-With-or-Without-Exemestane-in-Postmenopausal-Women-With-Estrogen-Receptor/103992/2012-01-27weekly0.1http://trialreach.com/study/Orthostatic-Dysregulation-and-Associated-Gastrointestinal-Dysfunction-in-Parkinsons-Disease---Evolution/119090/2012-01-27weekly0.1http://trialreach.com/study/Iron-Absorption-From-Biofortified-Beans-With-Different-Levels-of-Phytic-Acid/119070/2012-01-27weekly0.1http://trialreach.com/study/Computer-Assisted-Cognitive-Behavior-Therapy-for-Obsessive-Compulsive-Disorder-A-Comprehensive-Stepped-Care-Approach/119107/2012-01-27weekly0.1http://trialreach.com/study/Behavioral-Therapy-to-Treat-Urinary-Symptoms-in-Parkinson-Disease/119071/2012-01-27weekly0.1http://trialreach.com/study/Vitamin-E--Tocotrienol-Administered-to-Subjects-With-Resectable-Pancreatic-Exocrine-Neoplasia/78244/2012-01-27weekly0.1http://trialreach.com/study/A-Study-Examining-Doses-of-Abiraterone-Acetate-in-Adult-Women-With-21-Hydroxylase-Deficiency/119110/2012-01-27weekly0.1http://trialreach.com/study/Preparedness-Study---HPV-Vaccine/119091/2012-01-27weekly0.1http://trialreach.com/study/Mesenchymal-Stromal-Cells-as-Treatment-of-Chronic-Graft-versus-host-Disease/119073/2012-01-27weekly0.1http://trialreach.com/study/Pivotal-Clinical-Study-of-the-CardioFocus-Endoscopic-Ablation-System---Adaptive-Contact-EAS-AC-HeartLight-in-Patients-Wi/119087/2012-01-27weekly0.1http://trialreach.com/study/TMC435-TiDP16-C212---Trial-of-TMC435-in-Genotype-1-Hepatitis-C-and-Human-Immunodeficiency-Virus-Co-Infected-Patients/119129/2012-01-27weekly0.1http://trialreach.com/study/Telaprevir-Open-Label-Study-in-Co-Infected-Patients/119092/2012-01-27weekly0.1http://trialreach.com/study/Adenotonsillectomy-and-Obstructive-Sleep-Apnea-Study/119126/2012-01-27weekly0.1http://trialreach.com/study/Post-Stroke-Motor-Learning/119103/2012-01-27weekly0.1http://trialreach.com/study/Homoharringtonine-Omacetaxine-Mepesuccinate-in-Treating-Patients-With-Chronic-Myeloid-Leukemia-CML-With-the-T315I-BCR-AB/68038/2012-01-27weekly0.1http://trialreach.com/study/Split-face-Tolerability-Comparison-Between-Adapalene-BPO-Gel-Versus-Tretinoin-Gel/119072/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-JNS002-Doxorubicin-Hydrochloride-Liposome-Injection-in-Relapsed-or-Refractory-Multiple-Myeloma/88441/2012-01-27weekly0.1http://trialreach.com/study/124I-FIAU-Imaging-in-EBV-and-KSHV-Associated-Cancers/68908/2012-01-27weekly0.1http://trialreach.com/study/Functional-Performance-of-the-Journey-Deuce-Bicompartmental-Versus-the-Genesis-II-Total-Knee-System/92831/2012-01-27weekly0.1http://trialreach.com/study/Identification-of-New-Colorectal-Cancer-Genes/37065/2012-01-27weekly0.1http://trialreach.com/study/SafetyTolerabilityPharmacokinetic-PKPharmacodynamics-PD-Study-of-BMN701-in-Patients-With-Late-Onset-Pompe-Disease/102058/2012-01-27weekly0.1http://trialreach.com/study/Intra-arterial-Chemotherapy-for-the-Treatment-of-Intraocular-Retinoblastoma/94865/2012-01-27weekly0.1http://trialreach.com/study/Evaluation-of-the-Incidence-of-Cerebral-Lesions-Post-Pulmonary-Vein-Ablation-Catheter-PVAC/119117/2012-01-27weekly0.1http://trialreach.com/study/A-Efficacy-Safety-and-Tolerability-Study-of-Canagliflozin-in-Patients-With-Type-2-Diabetes-Mellitus-With-Inadequate-Glyc/102056/2012-01-27weekly0.1http://trialreach.com/study/Evaluation-of-Oral-Alpha-Cyclodextrin-for-Decreasing-Serum-Cholesterol/102012/2012-01-27weekly0.1http://trialreach.com/study/Mother-Daughter-Bone-Microarchitecture/100866/2012-01-27weekly0.1http://trialreach.com/study/Epidermal-Growth-Factor-Receptor-tested-Non-Small-Cell-Lung-Cancer-Patients-Treated-With-Erlotinib-Six-Months-or-Longer/119093/2012-01-27weekly0.1http://trialreach.com/study/aHUS-Observational-Long-Term-Follow-Up/119105/2012-01-27weekly0.1http://trialreach.com/study/Cerebellum-and-Cortical-Plasticity-the-Case-of-Dystonia/106455/2012-01-27weekly0.1http://trialreach.com/study/Study-of-Topically-Applied-Green-Tea-Extract-for-Radio-Dermatitis-and-Radiation-Mucositis/119131/2012-01-27weekly0.1http://trialreach.com/study/CoreValve-Advance-International-Post-Market-Study/99751/2012-01-27weekly0.1http://trialreach.com/study/Rapid-Renal-Sympathetic-Denervation-for-Resistant-Hypertension/119074/2012-01-27weekly0.1http://trialreach.com/study/Iontophoresis-Delivery-of-Dexamethasone-Phosphate-for-Non-infectious-Non-necrotizing-Anterior-Scleritis-Phase-1-Dose-var/99313/2012-01-27weekly0.1http://trialreach.com/study/COronary-Native-Artery-First-in-Man-Investigation-of-ISA-247-Elution-to-Prevent-Restenotic-Mechanisms-CONFIRM-1/42286/2012-01-27weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Cryoablation-Combined-With-Radiation-Therapy-for-the-Palliation-of-Painful-Bone-Metastases/119112/2012-01-27weekly0.1http://trialreach.com/study/Effects-of-Positive-Energy-Balance-and-Exercise-on-Appetite-Hormones-in-Sedentary-Men-and-Women/86995/2012-01-27weekly0.1http://trialreach.com/study/Pilot-Study-of-Interpersonal-and-Social-Rhythm-Therapy-for-Subthreshold-Bipolar/119094/2012-01-27weekly0.1http://trialreach.com/study/The-Surgical-Benefit-and-PtTolerability-Between-Two-Different-Bowel-Cleansing-Regimens-Performed-Prior-to-Pelvic-Reconst/119137/2012-01-27weekly0.1http://trialreach.com/study/Vaccine-Therapy-With-or-Without-Cyclophosphamide-in-Treating-Patients-Undergoing-Chemotherapy-and-Radiation-Therapy-for-/2239/2012-01-27weekly0.1http://trialreach.com/study/Study-of-Catheter-Based-Renal-Denervation-Therapy-in-Hypertension/119097/2012-01-27weekly0.1http://trialreach.com/study/A-Study-of-TMC435-in-Combination-With-Peginterferon-Alfa-2A-and-Ribavirin-for-Hepatitis-C-Virus-Genotype-1-Infected-Pati/101860/2012-01-27weekly0.1http://trialreach.com/study/Pilot-Study-of-Text-Message-Brief-Interventions-for-Problem-Drinkers/97655/2012-01-27weekly0.1http://trialreach.com/study/A-Dose-Finding-Study-Comparing-InSite-Vision-Inc-101-to-Vehicle-and-DuraSite-Alone-for-Dry-Eye-Disease/119138/2012-01-27weekly0.1http://trialreach.com/study/Longitudinal-Study-of-Symptoms-in-Colorectal-Cancer/31530/2012-01-27weekly0.1http://trialreach.com/study/Use-of-Rosuvastatin-in-HIV-Infected-Subjects-to-Modulate-Cardiovascular-Risks/100058/2012-01-27weekly0.1http://trialreach.com/study/The-Role-of-Glucocorticoid-Receptor-SNPs-in-Receptor-Function-and-Metabolic-Disease/108434/2012-01-27weekly0.1http://trialreach.com/study/The-Effect-of-Problem-Solving-Therapy-and-Antidepressant-Therapy-on-Cerebral-Perfusion-and-Brain-Derived-Neurotropic-Fac/94192/2012-01-27weekly0.1http://trialreach.com/study/Growth-and-Tolerance-of-Hypoallergenic-Formulas/86991/2012-01-27weekly0.1http://trialreach.com/study/Anonymous-Testing-of-Pathology-Specimens-for-BRCA-Mutations-in-Ashkenazi-Jewish-Individuals-Who-Have-Cancer/70462/2012-01-27weekly0.1http://trialreach.com/study/Changes-in-Tissue-Oxygenation-Following-Regional-Anesthesia/119135/2012-01-27weekly0.1http://trialreach.com/study/Study-of-a-Retroviral-Replicating-Vector-to-Treat-Patients-Undergoing-Surgery-for-a-Recurrent-Malignant-Brain-Tumor/113314/2012-01-27weekly0.1http://trialreach.com/study/Effect-of-an-Oral-Probiotic-Tablet-on-Oral-Bacteria-and-Clinical-Measurements-ProBiora3/119111/2012-01-27weekly0.1http://trialreach.com/study/Evaluation-of-Efficacy-and-Safety-of-Galantamine-in-Patients-With-Dementia-of-Alzheimers-Type-Who-Failed-to-Benefit-From/119119/2012-01-27weekly0.1http://trialreach.com/study/Ethanol-Lock-Therapy-for-Treatment-and-Secondary-Prophylaxis-of-Central-Line-Associated-Bloodstream-Infection/119075/2012-01-27weekly0.1http://trialreach.com/study/Advanced-Characterization-of-Autosomal-Dominant-Optic-Atrophy/119089/2012-01-27weekly0.1http://trialreach.com/study/PK-Switch-Efavirenz-to-Maraviroc-in-Patients-Initially-Suppressed-on-an-Efavirenz-containing-Regimen/89963/2012-01-27weekly0.1http://trialreach.com/study/Combination-Therapy-of-Topical-Imiquimod-Plus-Multipeptide-Vaccination-for-Cutaneous-Metastases-of-Melanoma/102135/2012-01-27weekly0.1http://trialreach.com/study/Combination-Chemotherapy-With-or-Without-Bevacizumab-in-Treating-Patients-With-Previously-Untreated-Stomach-Cancer-Gastr/84756/2012-01-27weekly0.1http://trialreach.com/study/Natural-History-of-Carotid-Atherosclerosis/119076/2012-01-27weekly0.1http://trialreach.com/study/Dexmedetomidine-in-Mechanically-Ventilated-Neonates-With-Single-Organ-Respiratory-Failure/111718/2012-01-27weekly0.1http://trialreach.com/study/iSONEP-to-Treat-Persistent-Pigment-Epithelial-Detachment-PED-in-Subjects-With-Exudative-Age-Related-Macular-Degeneration/107992/2012-01-27weekly0.1http://trialreach.com/study/Phase-3-Study-of-PSI-7977-and-Ribavirin/119136/2012-01-27weekly0.1http://trialreach.com/study/Atrium-iCAST-Iliac-Stent-Pivotal-Study/5499/2012-01-27weekly0.1http://trialreach.com/study/Virtual-Clinic-Pacemaker-Follow-up/60438/2012-01-27weekly0.1http://trialreach.com/study/Shorter-Course-Tacrolimus-After-Nonmyeloablative-Related-Donor-BMT-With-High-dose-Posttransplantation-Cyclophosphamide/95138/2012-01-27weekly0.1http://trialreach.com/study/Safety--Efficacy-of-TC-5619-in-Adults-With-Inattentive-predominant-Attention-DeficitHyperactivity-Disorder-ADHD/119080/2012-01-27weekly0.1http://trialreach.com/study/Open-Label-Bridging-Study-of-Telaprevir-in-Treatment-Nave-and-Treatment-Experienced-Russian-Patients-With-Genotype-1-Chr/119104/2012-01-27weekly0.1http://trialreach.com/study/A-Safety-Study-of-Abiraterone-Acetate-Administered-in-Combination-With-Docetaxel-in-Patients-With-Metastatic-Castration-/96107/2012-01-27weekly0.1http://trialreach.com/study/Efficacy-and-Safety-of-Masitinib-AB1010-in-Comparison-to-Placebo-in-the-Treatment-of-Patients-With-Smouldering-Systemic-/76660/2012-01-27weekly0.1http://trialreach.com/study/Effect-of-Aliskiren-and-Hydrochlorothiazide-on-Kidney-Oxygenation-in-Patients-With-Hypertension/119127/2012-01-27weekly0.1http://trialreach.com/study/Paliperidone-Palmitate-Effectiveness-Assessment-Registry---Longitudinal-PEARL/92051/2012-01-27weekly0.1http://trialreach.com/study/Clinical-Evaluation-of-Percutaneous-Implantation-of-the-Medtronic-CoreValve-Aortic-Valve-Prosthesis-18Fr-Study/49000/2012-01-27weekly0.1http://trialreach.com/study/Sedation-Influence-on-Delirium-and-Post-traumatic-Stress-disorder-as-a-Result-of-Hospitalization-in-Intensive-Care/109922/2012-01-27weekly0.1http://trialreach.com/study/Menstrual-Cycle-Maintenance-and-Quality-of-Life-A-Prospective-Study/77698/2012-01-27weekly0.1http://trialreach.com/study/Safety-and-Efficacy-of-Cryoablation-for-the-Palliation-of-Painful-Bone-Metastases/119077/2012-01-27weekly0.1http://trialreach.com/study/Comparison-Between-Three-Types-of-Stented-Pericardial-Aortic-Valves/119095/2012-01-27weekly0.1http://trialreach.com/study/Etude-Tomos--Apport-de-la-Tomosynthse-Dans-le-Bilan-dExtension-locorgional-prthrapeutique-dUne-Tumeur-du-Sein--Recherche/119115/2012-01-27weekly0.1http://trialreach.com/study/Detection-Rate-of-Liver-Metastases-With-Contrast-Enhanced-Intraoperative-Ultrasound-Compared-to-Regular-Imaging/119128/2012-01-27weekly0.1http://trialreach.com/study/Lenalidomide-in-Comb-wRituximab-for-Pts-wCD5CD20-Hem-Malig-Who-RelapseProgress-After-Rituximab/12557/2012-01-27weekly0.1http://trialreach.com/study/Aromatase-Inhibitors-in-Premenopausal-Breast-Cancer-Patients-With-Chemotherapy-Induced-Ovarian-Failure/11210/2012-01-27weekly0.1http://trialreach.com/study/Telepsychology-Service-Delivery-for-Depressed-Elderly-Veterans/3150/2012-01-27weekly0.1http://trialreach.com/study/Trial-of-pIL-12-Electroporation-Malignant-Melanoma/119118/2012-01-27weekly0.1http://trialreach.com/study/Cancer-Control-Following-Polypectomy/18473/2012-01-26weekly0.1http://trialreach.com/study/Study-of-Human-Placenta-derived-Cells-PDA001-to-Evaluate-the-Safety-and-Effectiveness-for-Patients-With-Active-Rheumatoi/101633/2012-01-26weekly0.1http://trialreach.com/study/Lenalidomide--Azacitidine-for-Adaptive-Immunotherapy---Auto-SCT-in-Multiple-Myeloma/21472/2012-01-26weekly0.1http://trialreach.com/study/Development-of-a-Clinical-Trial-Specific-Question-Prompt-List/20324/2012-01-26weekly0.1http://trialreach.com/study/Registry-of-AngioJet-Use-in-the-Peripheral-Vascular-System/97918/2012-01-26weekly0.1http://trialreach.com/study/Vitamin-D-Supplements-for-HIV-positive-Patients-on-cART/99072/2012-01-26weekly0.1http://trialreach.com/study/Modification-of-Cognitive-Processing-Therapy-CPT-C-for-Posttraumatic-Stress-Disorder-PTSD-and-Alcohol-Dependence-AD/24781/2012-01-26weekly0.1http://trialreach.com/study/A-12-week-Extension-of-the-Phase-III-Study-D3820C00004-to-Assess-the-Effect-and-Safety-of-NKTR-118-in-Patients-With-Non-/95113/2012-01-26weekly0.1http://trialreach.com/study/Immunogenicity-and-Safety-of-GSK-Biologicals-Boostrix-Polio-Vaccine-in-3-and-4-year-old-Children/111184/2012-01-26weekly0.1http://trialreach.com/study/EMD-521873-in-Advanced-Solid-Tumors-MTD-Finding/38486/2012-01-26weekly0.1http://trialreach.com/study/An-Observational-Study-of-Men-With-Premature-Ejaculation-Who-Are-Treated-With-Dapoxetine-Hydrochloride-or-Alternate-Care/43732/2012-01-26weekly0.1http://trialreach.com/study/Popliteal-Sciatic-Nerve-Block-Catheter-Placement-for-Foot-Surgery/34187/2012-01-26weekly0.1http://trialreach.com/study/Dasatinib-in-Resectable-Malignant-Pleural-Mesothelioma/46491/2012-01-26weekly0.1http://trialreach.com/study/Prospective-Evaluation-of-a-New-Covered-Metal-Stent-for-Malignant-Lesions-of-the-Esophagus/96305/2012-01-26weekly0.1http://trialreach.com/study/PALMFlexS-Paliperidone-Palmitate-Flexible-Dosing-in-Schizophrenia/87821/2012-01-26weekly0.1http://trialreach.com/study/Using-Videos-in-Advance-Care-Planning-for-Patients-With-Advanced-Cancer/111891/2012-01-26weekly0.1http://trialreach.com/study/Avonex-PEN-Satisfaction-and-Patients-Experience-Clinical-Trial/109479/2012-01-26weekly0.1http://trialreach.com/study/A-Study-of-Intradermal-Administration-of-ZOSTAVAX-V211-051-AM1/98346/2012-01-26weekly0.1http://trialreach.com/study/Germline-BRCA1-and-BRCA2-Mutations-in-Jewish-Women-Affected-by-Breast-Cancer/28096/2012-01-26weekly0.1http://trialreach.com/study/Efficacy-of-Endovascular-Catheter-Cooling-Combined-With-Cold-Saline-for-the-Treatment-of-Acute-Myocardial-Infarction/112597/2012-01-26weekly0.1http://trialreach.com/study/Safety-and-Efficacy-Study-of-ONGLYZA-Saxagliptin-Under-Conditions-of-Actual-Use/105540/2012-01-26weekly0.1http://trialreach.com/study/Influence-of-Male-Hormones-on-Regional-Fat-Metabolism/85356/2012-01-26weekly0.1http://trialreach.com/study/A-Study-To-Assess-The-Safety-And-Effectiveness-Of-Prevenar-In-Chinese-Children-Who-Have-Not-Previously-Received-A-Vaccin/108615/2012-01-26weekly0.1http://trialreach.com/study/The-Predictors-for-Asthma-Control-by-Stepwise-Treatment-During-6-Months-in-Korean-Elderly/95534/2012-01-26weekly0.1http://trialreach.com/study/Cervical-Cancer-Detection-Using-Optical-Spectroscopy/10309/2012-01-26weekly0.1http://trialreach.com/study/Comparison-of-Methods-for-the-Delivery-of-Interoceptive-Exposure/101801/2012-01-26weekly0.1http://trialreach.com/study/Early-Lung-Cancer-Diagnosis-in-HIV-Infected-Population-With-an-Important-Smoking-History-With-Low-Dose-CT-a-Pilot-Study/111970/2012-01-26weekly0.1http://trialreach.com/study/Cohort-of-HIV-Associated-Lymphomas/86363/2012-01-26weekly0.1http://trialreach.com/study/Prospective-Trial-of-Vaccine-Responses-Against-Pneumococcus-and-Influenza-in-Adult-Cancer-Patients-65-Years-of-Age-and-O/23373/2012-01-26weekly0.1http://trialreach.com/study/Endotracheal-Cardiac-Output-Monitor-ECOM-for-Patients-Undergoing-Liver-Transplantation/97182/2012-01-26weekly0.1http://trialreach.com/study/A-Study-of-HSP990-Administered-by-Mouth-in-Adult-Patients-With-Advanced-Solid-Tumors/38992/2012-01-26weekly0.1http://trialreach.com/study/Evaluation-of-an-Anti-cancer-Immunotherapy-Combined-With-Standard-Neoadjuvant-Treatment-in-Patients-With-WT1-positive-Pr/87796/2012-01-26weekly0.1http://trialreach.com/study/Single-Ascending-Dose-SADMultiple-Ascending-DoseMAD-SafetyPharmacokinetic-PK-Study-of-KM-023/109795/2012-01-26weekly0.1http://trialreach.com/study/A-Study-of-Intratumoral-CAVATAK-in-Patients-With-Stage-IIIc-and-Stage-IV-Malignant-Melanoma/108334/2012-01-26weekly0.1http://trialreach.com/study/Assessing-Depression-in-a-Geriatric-Cancer-Population/65607/2012-01-26weekly0.1http://trialreach.com/study/To-Evaluate-the-Effects-of-Multiple-Doses-of-Nilotinib-on-the-Pharmacokinetics-and-Metabolism-of-Midazolam-in-CML-Patien/95370/2012-01-26weekly0.1http://trialreach.com/study/Assessment-of-Long-Term-Infliximab-for-Psoriasis-Study-P05319/42588/2012-01-26weekly0.1http://trialreach.com/study/A-Multi-professional-Team-Intervention-on-Physical-Activity-Referrals-in-Primary-Care-Patients-With-Cardiovascular-Risk-/85287/2012-01-26weekly0.1http://trialreach.com/study/Sensory-Morbidity-Following-Breast-Surgery/8523/2012-01-26weekly0.1http://trialreach.com/study/A-Randomized-Double-Blind-Placebo-Controlled-Study-of-Omalizumab-for-Idiopathic-Anaphylaxis/69575/2012-01-26weekly0.1http://trialreach.com/study/Comparison-of-Efficacy-and-Safety-of-Infant-Peri-exposure-Prophylaxis-With-LopinavirRitonavir-Versus-Lamivudine-to-Preve/40314/2012-01-26weekly0.1http://trialreach.com/study/A-Long-Term-Safety-And-Tolerability-Extension-Study-Of-Bapineuzumab-In-Alzheimer-Disease-Patients/45246/2012-01-26weekly0.1http://trialreach.com/study/A-Safety-and-Tolerability-Study-of-Doripenem-Compared-With-Cefepime-in-Hospitalized-Children-With-Bacterial-Pneumonia/111820/2012-01-26weekly0.1http://trialreach.com/study/Study-Testing-the-Biologic-Activity-and-Safety-of-an-Immunotherapeutic-in-Patients-With-Newly-Diagnosed-Stage-IV-Kidney-/27883/2012-01-26weekly0.1http://trialreach.com/study/A-Safety-and-Tolerability-Study-of-Doripenem-Compared-With-Cefepime-in-Children-Hospitalized-With-Complicated-Urinary-Tr/100270/2012-01-26weekly0.1http://trialreach.com/study/A-Phase-1-Study-of-CNTO-328-Siltuximab-in-Relapsed-or-Refractory-Multiple-Myeloma/88587/2012-01-26weekly0.1http://trialreach.com/study/EP46-NOVAA-The-Yellow-Fever-Vaccine-Immunity-in-HIV-Infected-Patients--Development-of-New-Assays-for-Virological-and-Imm/119044/2012-01-26weekly0.1http://trialreach.com/study/A-Prospective-Randomized-Trial-Using-Video-Images-in-Advance-Care-Planning-in-Seriously-Ill-Hospitalized-Patients/100675/2012-01-26weekly0.1http://trialreach.com/study/A-Study-of-the-Safety-and-Effectiveness-of-Trabetedin-Versus-Doxorubicin-based-Chemotherapy-in-Patients-With-Translocati/41585/2012-01-26weekly0.1http://trialreach.com/study/Multicenter-Study-of-Long-Term-Clinical-Outcomes-of-Subcutaneous-Immune-Globulin-IgPro20-in-Subjects-With-Primary-Immuno/112970/2012-01-26weekly0.1http://trialreach.com/study/Prazosin-for-Treatment-of-Patients-With-Alcohol-Dependence-AD-and-Post-Traumatic-Stress-Disorder-PTSD/43831/2012-01-26weekly0.1http://trialreach.com/study/THRAhematologic-Variables/118984/2012-01-26weekly0.1http://trialreach.com/study/Enhancing-Oral-Health-Care-Use-by-HIV-Positive-Individuals/8199/2012-01-26weekly0.1http://trialreach.com/study/A-Study-of-Doripenem-in-CerebrospinalFluid-After-Doripenem-Administration-in-Pediatric-Patients-Less-Than-1-Year-of-Age/105835/2012-01-26weekly0.1http://trialreach.com/study/Intraepithelial-Neoplasia-Detection-Rate-After-Single-Oral-Dose-of-Methylene-Blue-MMX-Modified-Release-Tablets-Administe/119041/2012-01-26weekly0.1http://trialreach.com/study/Safety-Tolerability-and-Pharmacokinetic-First-in-Human-FIH-Study-of-Intravenous-IV-TKM-100201-Infusion/118983/2012-01-26weekly0.1http://trialreach.com/study/Bortezomib-and-Romidepsin-in-Chronic-Lymphocytic-LeukemiaSmall-Lymphocytic-Lymphoma/11924/2012-01-26weekly0.1http://trialreach.com/study/Clinical-Study-of-Droxidopa-in-Patients-With-Neurogenic-Orthostatic-Hypotension-NOH-Droxi-304/86078/2012-01-26weekly0.1http://trialreach.com/study/Effect-of-Imatinib-on-Bone-Metabolism-in-Patients-With-Chronic-Myelogenous-Leukemia-or-Gastrointestinal-Stromal-Tumors/34537/2012-01-26weekly0.1http://trialreach.com/study/Trial-of-Vaccine-Therapy-in-Recurrent-Platinum-Resistant-Ovarian-Cancer-Patients/95338/2012-01-26weekly0.1http://trialreach.com/study/Follow-up-Study-of-Subcutaneous-Immune-Globulin-in-Patients-Requiring-IgG-Replacement-Therapy-Japan-Study/112709/2012-01-26weekly0.1http://trialreach.com/study/Study-of-Economic-Circumstances-Service-Utilization-and-Service-Needs-Among-Older-Colon-Cancer-Patients/22584/2012-01-26weekly0.1http://trialreach.com/study/Study-Evaluating-Prevenar-in-the-Prevention-of-Invasive-Pneumococcal-Disease-IPD-in-the-Paediatric-Population-in-Spain/84733/2012-01-26weekly0.1http://trialreach.com/study/Diabetes-in-Europe---Prevention-Using-Lifestyle-Physical-Activity-and-Nutritional-Intervention-in-Catalonia/118973/2012-01-26weekly0.1http://trialreach.com/study/Pharmacokinetics-and-Tolerability-Study-of-Tapentadol-for-Postsurgical-Pain-in-Children-and-Adolescents/112472/2012-01-26weekly0.1http://trialreach.com/study/Genetic-Evaluation-of-Natalizumab-Treated-Patients-With-Progressive-Multifocal-Leukoencephalopathy/87824/2012-01-26weekly0.1